# The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients

Authors: Yanqiu Zhang; A’meng Han; Zhanzhao Fu; Shufeng Xu; Zijian Zhang
Journal: BioMed Research International
 (2019)

---

## Abstract

Currently, studies about PORT in stage IIIA-N2 NSCLC patients in recent years have mostly adopted the conformal radiation therapy (CRT) technique, while other modern techniques such as intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT, hereinafter referred to as ARC), helical tomotherapy (HT), and so forth are also developing quickly. In this paper, we intended to compare the dosimetric characteristics of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of PORT in stage IIIA-N2 NSCLC patients. Ten patients with stage IIIA-N2 completely resected NSCLC, whom were treated by PORT in the radiotherapy department of our hospital from January 1, 2017, to January 1, 2018, were randomly selected in this study. For each patient, the CRT plan, IMRT plan, ARC plan, CRT+IMRT plan, and CRT+ARC plan were designed separately on the same set of CT images. The isodose distribution and dose-volume histogram (DVH) of the five plans were compared to determine the dosimetric parameters of the targets, OAR (organs at risk), and the normal tissue (defined as body subtracted to PTV (planning target volume), B-P). No plan had absolute dosimetry advantages than any other plans. In clinical practice, the plans could be chosen according to their dosimetry characteristics.


---

## Body

## 1. Introduction

There were many controversies about postoperative radiotherapy (PORT) in IIIA non-small-cell lung cancer (NSCLC) patients with pathologically confirmed N2. For one thing, local recurrence and distant metastasis were the main reasons for treatment failure of PORT in stage IIIA-N2 NSCLC patients, as the local recurrence rate and distant metastasis rate were 23%~33% and more than 50%, respectively [1]. Furthermore, stage IIIA-N2 NSCLC patients had increased local control rates and decreased recurrence rates after surgery. However, as for survival rate, different researchers have different conclusions [2–4]. To analyze reasons for the different conclusions, one reason may be a slight difference in the standard of tumor staging in different periods. Another reason may be using different treatment models in different periods, while a third reason may be due to development stage of the radiotherapy techniques used.Since the 1990s, radiotherapy techniques developed from two-dimensional techniques to three-dimensional precise radiotherapy techniques gradually. The three-dimensional precise radiotherapy techniques mainly contain conformal radiation therapy (CRT) and intensity modulated radiation therapy (IMRT). The IMRT has fix field IMRT, volumetric modulated arc therapy (VMAT, hereinafter referred to as ARC), and helical tomotherapy (HT). The CRT, IMRT, and ARC have been used widely in most hospitals in China and each has technical advantages of their own. The CRT is relatively safe and stable with higher marginal dose of tumor while IMRT has good conformability and uniformity. However, the VMAT not only has good conformability and uniformity, but also faster treatment efficiency and fewer machine units.The studies about PORT in stage IIIA-N2 NSCLC patients in the past have all adopted two-dimensional techniques and/or CRT techniques and seldom IMRT or VMAT techniques. In this study, we intended to compare the dosimetric characteristics of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of PORT in stage IIIA-N2 NSCLC patients. We hoped that our study results would provide evidence for the clinical application of above techniques.


## 2. Materials and Methods

### 2.1. Patients Selection and General Information

Ten patients with stage IIIA-N2 completely resected NSCLC, treated by PORT in radiotherapy department of our hospital from January 1, 2017, to January 1, 2018, were randomly selected in this study. There were 3 women and 7 men, aged 51~69 years, with a median age of 65 years. Planning Target Volume (PTV) was 178.2~430.8cc. The general clinical data of patients is shown in Table1.Table 1
General clinical data of patients.
Case no. Age (yeas) Sex T stage N stage M stage Clinical stage Pathological pattern PTV volume (cc) 01 Female 68 2 2 0 IIIA Adenocarcinoma 220.5 02 Female 63 2 2 0 IIIA Adenocarcinoma 197.0 03 Male 64 3 2 0 IIIA Adenocarcinoma 373.3 04 Male 65 3 2 0 IIIA Squamous cell carcinoma 430.8 05 Male 65 3 2 0 IIIA Squamous cell carcinoma 389.1 06 Male 69 2 2 0 IIIA Squamous cell carcinoma 293.9 07 Male 51 2 2 0 IIIA Squamous cell carcinoma 184.7 08 Female 63 1b 2 0 IIIA Adenocarcinoma 178.2 09 Male 67 3 2 0 IIIA Large cell carcinoma 264.0 10 Male 62 1a 2 0 IIIA Adenocarcinoma 367.7


### 2.2. Position Immobilized and CT Scans

Patients were lying on a CT bed in supine position and immobilized using thermoplastic masks. The Ge Corp CT scanner was used to simulate the positioning. The scanning thickness and spacing were both 2.5 mm. The CT images were transmitted to the ARIA server via the Varian ARIA oncology management software. Then images were received to local at treatment planning system (TPS) terminal.


### 2.3. Delineation of Targets and Organs at Risk (OARs)

On TPS, targets and the OARs were delineated by a chief physician. According to the grouping and distribution criteria of mediastinal lymph nodes proposed by IASCLC in 2009, as for left NSCLC after complete resection, the targets included bronchial stump, 2R, 2L, 4R, 4L, 5, 6, 7, 10L, and 11L lymph nodes. As for right NSCLC after complete resection, the targets included bronchial stump, 2R, 4R, 7, 10R, and 11R lymph nodes. The OARs included spinal cord, esophagus, heart and double lung.


### 2.4. Treatment Plans Design

The plans were designed by a senior physicist in Varian Corporation Eclipse TPS (Eclipse version 10.0, Varian Medical Systems, Palo Alto, CA). For each patient, five plans were designed on the same set of CT images. 6 MV X-ray was selected, and the location of the field centers was the same. The first plan was CRT plan. Five fields were chosen for the CRT plan. The angle of fields depended on the location of tumors and followed the principle of “design fields near tumors”. Conformity and homogeneity of targets were improved by adjusting fields' weight and “field in field” techniques and avoided “hot points” and “cold points” at the same time. The second plan was IMRT plan. Five fields were also chosen for the IMRT plan and field angles were as same as the CRT plan. By setting appropriate optimization conditions and repeatedly optimizing, a plan meeting the clinical requirements was finally obtained. The third plan was ARC plan. There were two partial arcs for the ARC plan and arc positions were near tumors. The angle of collimator was 10° and 350°, respectively. The optimization conditions were the same as the IMRT plan and a plan meeting clinical requirements was finally obtained by repeated optimization.The fourth plan was CRT+IMRT plan. Two opposing fields were chosen for the CRT plan and three fields for the IMRT plan. The three fields of IMRT plan distributed nearly as equal angle in the ipsilateral lung. Then the IMRT plan optimized based on the CRT plan, the optimization conditions were as same as the ARC plan and a plan meeting the clinical requirements was finally obtained by repeated optimization. The fifth plan was CRT+ARC plan. The CRT was the same as the CRT+IMRT plan. One partial arc was chosen for the ARC plan and optimized based on the CRT plan. The angle of collimator was 10° or 350°. The optimization conditions were the same as the CRT+IMRT plan and a plan meeting clinical requirements was finally obtained by repeated optimization.Dose calculation of all plans was performed using analytical anisotropic algorithm (AAA). The prescription of five plans for the same patient was the same as 50 Gy, and the fraction dose was 2 Gy, a total of 25 times. The dose ratio of CRT and IMRT or ARC was 1:1. According to the NCCN guideline and related research results, the dose-limiting conditions were as follows: the prescription line encompassed over 95% of the target volume; the maximum dose of the spinal cord was less than 45 Gy; the V5 of the esophagus was less than 50%; the V30 and V40 of the heart were less than 40% and 30%, respectively; and the normal doses of normal lung volume V5, V20, and V30 were less than 60%, 25%, 20%, and 15 Gy, respectively.


### 2.5. Evaluation Methods

The isodose distribution and dose-volume histogram (DVH) of the five plans were compared to determine the dosimetric parameters of the targets, OARs, and the normal tissue (defined as Body subtracted to PTV, B-P). The targets were evaluated by the minimum dose, the maximum dose, the median dose, Homogeneity index (HI), Conformity index (CI), and the volume of the targets which were irradiated by higher than 105% prescription dose V105. HI and CI were calculated using the following equations:(1)HI=D2-D98Dp×100%;CI=Vt,refVt×Vt,refVrefD2 and D98 refer to the maximum dose encompassing 2% and 98% of PTV, respectively, Dp is the prescription dose. Vt is the volume of PTV, Vt,ref is the volume of PTV covered by reference isodose line, and Vref is the volume of the body covered by reference isodose line.The following parameters were used to evaluate the protection of OARs: the maximum dose of spinal cord; the V50 and maximum dose of esophagus; V20, V30, V40, V45, and average dose of heart; V5, V13, V20, V30, and average dose of double lung. The Vx here refers to the percentage of tissue exposed to X and Gy to the total volume. The percentage of B-P exposure to 5~50 Gy volume and B-P volume, V5~50. In addition, the number of machine units (MU) for the five plans was also evaluated.


## 2.1. Patients Selection and General Information

Ten patients with stage IIIA-N2 completely resected NSCLC, treated by PORT in radiotherapy department of our hospital from January 1, 2017, to January 1, 2018, were randomly selected in this study. There were 3 women and 7 men, aged 51~69 years, with a median age of 65 years. Planning Target Volume (PTV) was 178.2~430.8cc. The general clinical data of patients is shown in Table1.Table 1
General clinical data of patients.
Case no. Age (yeas) Sex T stage N stage M stage Clinical stage Pathological pattern PTV volume (cc) 01 Female 68 2 2 0 IIIA Adenocarcinoma 220.5 02 Female 63 2 2 0 IIIA Adenocarcinoma 197.0 03 Male 64 3 2 0 IIIA Adenocarcinoma 373.3 04 Male 65 3 2 0 IIIA Squamous cell carcinoma 430.8 05 Male 65 3 2 0 IIIA Squamous cell carcinoma 389.1 06 Male 69 2 2 0 IIIA Squamous cell carcinoma 293.9 07 Male 51 2 2 0 IIIA Squamous cell carcinoma 184.7 08 Female 63 1b 2 0 IIIA Adenocarcinoma 178.2 09 Male 67 3 2 0 IIIA Large cell carcinoma 264.0 10 Male 62 1a 2 0 IIIA Adenocarcinoma 367.7


## 2.2. Position Immobilized and CT Scans

Patients were lying on a CT bed in supine position and immobilized using thermoplastic masks. The Ge Corp CT scanner was used to simulate the positioning. The scanning thickness and spacing were both 2.5 mm. The CT images were transmitted to the ARIA server via the Varian ARIA oncology management software. Then images were received to local at treatment planning system (TPS) terminal.


## 2.3. Delineation of Targets and Organs at Risk (OARs)

On TPS, targets and the OARs were delineated by a chief physician. According to the grouping and distribution criteria of mediastinal lymph nodes proposed by IASCLC in 2009, as for left NSCLC after complete resection, the targets included bronchial stump, 2R, 2L, 4R, 4L, 5, 6, 7, 10L, and 11L lymph nodes. As for right NSCLC after complete resection, the targets included bronchial stump, 2R, 4R, 7, 10R, and 11R lymph nodes. The OARs included spinal cord, esophagus, heart and double lung.


## 2.4. Treatment Plans Design

The plans were designed by a senior physicist in Varian Corporation Eclipse TPS (Eclipse version 10.0, Varian Medical Systems, Palo Alto, CA). For each patient, five plans were designed on the same set of CT images. 6 MV X-ray was selected, and the location of the field centers was the same. The first plan was CRT plan. Five fields were chosen for the CRT plan. The angle of fields depended on the location of tumors and followed the principle of “design fields near tumors”. Conformity and homogeneity of targets were improved by adjusting fields' weight and “field in field” techniques and avoided “hot points” and “cold points” at the same time. The second plan was IMRT plan. Five fields were also chosen for the IMRT plan and field angles were as same as the CRT plan. By setting appropriate optimization conditions and repeatedly optimizing, a plan meeting the clinical requirements was finally obtained. The third plan was ARC plan. There were two partial arcs for the ARC plan and arc positions were near tumors. The angle of collimator was 10° and 350°, respectively. The optimization conditions were the same as the IMRT plan and a plan meeting clinical requirements was finally obtained by repeated optimization.The fourth plan was CRT+IMRT plan. Two opposing fields were chosen for the CRT plan and three fields for the IMRT plan. The three fields of IMRT plan distributed nearly as equal angle in the ipsilateral lung. Then the IMRT plan optimized based on the CRT plan, the optimization conditions were as same as the ARC plan and a plan meeting the clinical requirements was finally obtained by repeated optimization. The fifth plan was CRT+ARC plan. The CRT was the same as the CRT+IMRT plan. One partial arc was chosen for the ARC plan and optimized based on the CRT plan. The angle of collimator was 10° or 350°. The optimization conditions were the same as the CRT+IMRT plan and a plan meeting clinical requirements was finally obtained by repeated optimization.Dose calculation of all plans was performed using analytical anisotropic algorithm (AAA). The prescription of five plans for the same patient was the same as 50 Gy, and the fraction dose was 2 Gy, a total of 25 times. The dose ratio of CRT and IMRT or ARC was 1:1. According to the NCCN guideline and related research results, the dose-limiting conditions were as follows: the prescription line encompassed over 95% of the target volume; the maximum dose of the spinal cord was less than 45 Gy; the V5 of the esophagus was less than 50%; the V30 and V40 of the heart were less than 40% and 30%, respectively; and the normal doses of normal lung volume V5, V20, and V30 were less than 60%, 25%, 20%, and 15 Gy, respectively.


## 2.5. Evaluation Methods

The isodose distribution and dose-volume histogram (DVH) of the five plans were compared to determine the dosimetric parameters of the targets, OARs, and the normal tissue (defined as Body subtracted to PTV, B-P). The targets were evaluated by the minimum dose, the maximum dose, the median dose, Homogeneity index (HI), Conformity index (CI), and the volume of the targets which were irradiated by higher than 105% prescription dose V105. HI and CI were calculated using the following equations:(1)HI=D2-D98Dp×100%;CI=Vt,refVt×Vt,refVrefD2 and D98 refer to the maximum dose encompassing 2% and 98% of PTV, respectively, Dp is the prescription dose. Vt is the volume of PTV, Vt,ref is the volume of PTV covered by reference isodose line, and Vref is the volume of the body covered by reference isodose line.The following parameters were used to evaluate the protection of OARs: the maximum dose of spinal cord; the V50 and maximum dose of esophagus; V20, V30, V40, V45, and average dose of heart; V5, V13, V20, V30, and average dose of double lung. The Vx here refers to the percentage of tissue exposed to X and Gy to the total volume. The percentage of B-P exposure to 5~50 Gy volume and B-P volume, V5~50. In addition, the number of machine units (MU) for the five plans was also evaluated.


## 3. Statistical Analysis

SPSS 22 software package was used for statistical description and analysis of the data. The paired t test was performed to test comparisons between two plans. A 2-tailed P-value of < 0.05 was considered statistically significant.


## 4. Results

### 4.1. CRT Plan versus IMRT Plan

As shown in Table2, the minimum dose of PTV in the CRT pan was better than the IMRT plan, and the difference was statistically significant, t=6.698,p=0.001.However, the Conformity index and V105 (%) of PTV in the CRT plan were worse than the IMRT plan, and the differences were statistically significant, t=-5.367,2.359,p=0.001,0.043.The other dosimetric parameters of PTV in the CRT plan had no statistical differences compared with the IMRT plan.Table 2
Comparisons of PTV, OAR, and B-P dosimetric parameters between CRT plan and IMRT plan (cGy,x-±s).
Dosimetric parameters CRT plan IMRT plan Difference t value P value PTV Minimum dose/cGy 4353.71±69.41 3936.34±189.77 417.37±197.05 6.698 0.001 Maximum dose/cGy 5397.29±82.69 5350.08±61.15 47.21±108.72 1.373 0.203 Median dose/cGy) 5001.56±14.33 4979.08±77.62 22.48±81.23 0.875 0.404 Conformity index 0.69±0.05 0.80±0.04 -0.11±0.06 -5.367 0.001 Homogeneity index 0.21±0.02 0.28±0.04 -0.00±0.03 -0.330 0.749 V105 (%) 15.11±3.64 2.92±4.38 12.19±16.34 2.359 0.043 OAR Spinal cord Maximum dose 3214.23±285.34 2636.20±179.98 578.02±259.87 7.034 0.001 Esophagus V50 (%) 8.49±9.94 17.79±14.08 -9.30±16.53 -1.778 0.109 Maximum dose 5110.67±113.32 5270.17±109.33 -159.50±132.28 -3.813 0.004 Heart V20 (%) 23.77±21.93 20.78±21.65 2.97±1.75 5.382 0.001 V30 (%) 11.98±12.97 9.83±10.15 2.15±3.10 2.191 0.056 V40 (%) 6.92±7.43 4.87±5.24 2.05±2.26 2.864 0.019 V45 (%) 5.15±5.48 3.59±3.84 1.55±1.73 2.832 0.020 Mean dose 1061.75±777.82 932.07±702.92 129.68±83.46 4.913 0.001 Normal lung V5 (%) 54.24±8.06 49.59±6.17 4.64±2.27 6.456 0.001 V10 (%) 37.28±8.74 35.13±7.42 2.14±2.55 2.653 0.026 V13 (%) 33.62±7.95 30.31±6.38 3.29±2.25 4.636 0.001 V20 (%) 26.62±7.23 22.22±4.48 4.40±2.32 5.982 0.001 V30 (%) 11.59±1.64 8.63±1.47 2.95±1.38 6.771 0.001 Mean dose 1006.29±522.53 1040.41±147.82 -34.12±418.64 -0.258 0.802 B-P V5(%) 27.31±8.42 22.91±2.48 4.39±7.40 1.879 0.093 V10(%) 18.97±5.53 15.73±2.21 3.24±4.37 2.347 0.044 V15(%) 16.03±4.77 12.55±1.83 3.48±3.84 2.870 0.018 V20(%) 12.49±4.87 9.29±1.79 3.19±4.28 2.363 0.042 V25(%) 7.33±3.41 5.19±1.40 2.13±3.05 2.216 0.054 V30(%) 4.29±2.76 2.73±0.81 1.56±2.45 2.015 0.075 V35(%) 2.94±2.29 1.51±0.46 1.44±1.97 2.317 0.046 V40(%) 1.95±1.32 0.71±0.20 1.24±1.23 3.181 0.011 V45(%) 1.24±1.06 0.28±0.10 0.95±1.01 2.957 0.016 V50(%) 0.23±0.24 0.03±0.03 0.19±.22 2.771 0.022As for OARs, V50 (%) of esophagus, V30 (%) of heart, and the mean dose of normal lung in the CRT plan had no statistical differences compared with the IMRT plan. The maximum dose of spinal cord in the CRT plan was higher than the IMRT plan, and the difference was statistically significant, t=7.034, p=0.001.The maximum dose of esophagus was lower than the IMRT plan, and the difference was statistically significant, t=-3.813, p=0.004. The V20 (%), V40 (%), V45 (%), and mean dose of heart in the CRT plan were all higher than the IMRT plan, and the differences were statistically significant, t=5.382,2.864,2.832,4.913, p=0.001,0.019,0.020,0.001. The V5 (%), V10 (%), V13 (%), V20 (%), and V30 (%) of normal lung in the CRT plan were all higher than the IMRT plan, and the differences were statistically significant, t=6.456,2.653,4.636,5.982,6.771, p=0.001,0.026,0.001,0.001,0.001; see Table 2 for details.As for B-P, theV5~50 of B-P in the CRT plan were all higher than the IMRT plan, and the differences were not statistically significant for V5, V25, and V30, but the differences were statistically significant for V10, V15, V20, V35, V40, V45, V50,t=2.347, 2.870, 2.363, 2.317, 3.181, 2.957, 2.771, p=0.044,0.018,0.042,0.046,0.011,0.016,0.022;see Table 2 for details.


### 4.2. CRT Plan versus ARC Plan

As shown in Table3, the median dose, the Conformity index, and V105 (%) of PTV in the CRT pan were worse than the ARC plan, and the differences were statistically significant,t=-4.433, -15.148, 2.766, p=0.002, 0.001, 0.022.The other dosimetric parameters of PTV in the CRT plan had no statistical differences compared with the ARC plan.Table 3
Comparisons of PTV, OAR, and B-P dosimetric parameters between CRT plan and ARC plan(cGy,x-±s).
Dosimetric parameters CRT plan ARC plan Difference tvalue Pvalue PTV Minimum dose/cGy 4353.71±69.41 4285.12±159.09 68.59±165.02 1.314 0.221 Maximum dose/cGy 5397.29±82.69 5348.30±61.22 48.99±100.59 1.540 0.158 Median dose/cGy) 5001.56±14.33 5025.60±6.27 -24.04±17.14 -4.433 0.002 Conformity index 0.69±0.05 0.88±0.02 -0.19±0.04 -15.148 0.001 Homogeneity index 0.21±0.02 0.21±0.04 -0.00±0.04 -0.330 0.749 V105 (%) 15.11±3.64 0.74±.84 14.37±16.43 2.766 0.022 OAR Spinal cord Maximum dose 3214.23±285.34 2383.08±353.89 831.15±476.47 5.516 0.001 Esophagus V50 (%) 8.49±9.94 19.48±12.51 -10.99±8.11 -4.286 0.002 Maximum dose 5110.67±113.32 4863.6±1253.24 -611.56±1105.668 0.651 0.531 Heart V20 (%) 23.77±21.93 13.98±13.25 3.21±16.34 3.369 0.008 V30 (%) 11.98±12.97 6.66±6.03 0.29±10.33 2.393 0.040 V40 (%) 6.92±7.43 3.79±3.21 0.04±6.23 2.295 0.047 V45 (%) 5.15±5.48 2.89±2.45 0.01±4.49 2.278 0.049 Mean dose 1061.75±777.82 698.58±652.93 100.58±625.75 3.129 0.012 Normal lung V5 (%) 54.24±8.06 56.06±6.17 -5.33±1.66 -1.186 0.266 V10 (%) 37.28±8.74 36.61±7.24 -1.71±3.07 0.643 0.536 V13 (%) 33.62±7.95 29.20±6.20 1.82±7.01 3.860 0.004 V20 (%) 26.62±7.23 19.49±3.34 3.59±10.68 4.551 0.001 V30 (%) 11.59±1.64 8.85±0.90 1.55±3.91 5.244 0.001 Mean dose 1006.29±522.53 972.39±362.74 -344.47±412.264 0.203 0.844 B-P V5(%) 27.31±8.42 26.15±3.14 -3.97±6.30 0.514 0.619 V10(%) 18.97±5.53 16.54±2.41 -0.86±5.72 1.667 0.130 V15(%) 16.03±4.77 10.97±1.80 2.28±7.82 4.121 0.003 V20(%) 12.49±4.87 6.46±1.43 3.22±8.84 4.861 0.001 V25(%) 7.33±3.41 3.72±0.93 1.64±5.58 4.142 0.003 V30(%) 4.29±2.76 2.13±0.55 0.39±3.92 2.774 0.022 V35(%) 2.94±2.29 1.22±0.29 0.18±3.27 2.532 0.032 V40(%) 1.95±1.32 0.66±0.14 0.39±2.19 3.244 0.010 V45(%) 1.24±1.06 0.25±0.04 0.24±1.74 2.999 0.015 V50(%) 0.23±0.24 0.00±0.00 0.01±0.05 3.748 0.005As for OARs, the maximum dose of spinal cord in the CRT plan was higher than the ARC plan, and the difference was statistically significant,t=5.516, p=0.001.The V50 (%) of esophagus was lower than the ARC plan, and the difference was statistically significant,t=-4.286, p=0.002. But the maximum dose of esophagus in the CRT plan had no statistical differences compared with the ARC plan. The V20 (%), V30 (%), V40 (%), V45 (%), and mean dose of heart in the CRT plan were all higher than the ARC plan, and the differences were statistically significant,t=3.369, 2.393, 2.295, 2.278, 3.129, p=0.008, 0.040, 0.047, 0.049, 0.012.The V5 (%), V10 (%), and mean dose of normal lung in the CRT plan had no statistical differences compared with the ARC plan. However, the V13 (%), V20 (%), and V30 (%) of normal lung in the CRT plan were all higher than the ARC plan, and the differences were statistically significant,t=3.860, 4.551, 5.244, p=0.004, 0.001, 0.001;see Table 3 for details.As for B-P, theV5~50 of B-P in the CRT plan were all higher than the ARC plan, and the differences were not statistically significant for V5, and V10, but the differences were statistically significant for V15, V20, V30, V35, V40, V45, V50,t=4.121, 4.861, 4.142, 2.774, 2.532, 3.244, 2.999, 3.748, p=0.003, 0.001, 0.003, 0.022, 0.032, 0.010, 0.015, 0.005;see Table 3 for details.


### 4.3. CRT Plan versus CRT+IMRT Plan

As shown in Table4, the median dose and the Conformity index of PTV in the CRT pan were worse than the CRT+IMRT plan, and the differences were statistically significant,t=-2.604, -7.910, p=0.001, 0.015.The other dosimetric parameters of PTV in the CRT plan had no statistical differences compared with the IMRT plan.Table 4
Comparisons of PTV, OAR, and B-P dosimetric parameters between CRT plan and CRT+IMRT plan(cGy,x-±s).
Dosimetric parameters CRT plan CRT+IMRT plan Difference tvalue Pvalue PTV Minimum dose/cGy 4353.71±69.41 4051.12±183.68 302.59±62.84 4.815 0.001 Maximum dose/cGy 5397.29±82.69 5373.66±103.43 23.63±50.75 0.466 0.653 Median dose/cGy) 5001.56±14.33 5017.78±9.25 -16.22±6.23 -2.604 0.029 Conformity index 0.69±0.05 0.80±0.03 -0.11±0.04 -7.910 0.001 Homogeneity index 0.21±0.02 0.27±0.05 -0.06±0.06 -3.006 0.015 V105 (%) 15.11±3.64 3.48±5.16 11.63±19.11 1.924 0.086 OAR Spinal cord Maximum dose 3214.23±285.34 3181.48±556.33 32.75±188.93 0.173 0.866 Esophagus V50 (%) 8.49±9.94 14.68±13.39 -6.19±10.77 -1.817 0.103 Maximum dose 5110.67±113.32 5205.15±96.40 -94.48±109.08 -2.739 0.023 Heart V20 (%) 23.77±21.93 20.76±21.46 3.00±3.26 2.913 0.017 V30 (%) 11.98±12.97 13.12±15.14 -1.14±2.68 -1.347 0.211 V40 (%) 6.92±7.43 5.32±5.49 1.60±2.11 2.391 0.041 V45 (%) 5.15±5.48 3.86±4.20 1.29±1.36 2.996 0.015 Mean dose 1061.75±777.82 983.30±742.64 78.45±83.12 2.985 0.015 Normal lung V5 (%) 54.24±8.06 46.88±7.19 7.35±4.28 5.435 0.001 V10 (%) 37.28±8.74 31.74±6.64 5.54±5.24 3.342 0.009 V13 (%) 33.62±7.95 24.71±4.66 8.90±5.54 5.082 0.001 V20 (%) 26.62±7.23 17.95±2.56 8.67±5.32 5.153 0.001 V30 (%) 11.59±1.64 11.34±2.11 0.24±1.68 0.457 0.659 Mean dose 1006.29±522.53 1001.52±127.12 4.77±447.35 0.034 0.974 B-P V5(%) 27.31±8.42 20.49±2.71 6.83±7.07 3.053 0.014 V10(%) 18.97±5.53 14.32±2.43 4.65±3.90 3.780 0.004 V15(%) 16.03±4.77 11.92±3.92 4.11±1.13 11.481 0.001 V20(%) 12.49±4.87 10.04±3.22 2.45±1.81 4.287 0.002 V25(%) 7.33±3.41 8.32±2.76 -0.98±1.56 -1.992 0.078 V30(%) 4.29±2.76 5.76±2.33 -1.47±1.16 -3.967 0.003 V35(%) 2.94±2.29 3.27±1.80 -0.32±0.78 -1.282 0.232 V40(%) 1.95±1.32 1.72±1.46 0.24±0.24 3.209 0.011 V45(%) 1.24±1.06 0.87±1.03 0.37±0.12 9.582 0.001 V50(%) 0.23±0.24 0.06±0.06 0.17±0.20 2.730 0.023As for OARs, the maximum dose of spinal cord in the CRT plan had no statistical difference compared with the CRT+IMRT plan.The maximum dose of esophagus was lower in the CRT plan than the CRT+IMRT plan, and the difference was statistically significant,t=-2.739, p=0.023. But the V50 (%) of esophagus in the CRT plan had no statistical difference compared with the CRT+IMRT plan. The V20 (%), V40 (%), V45 (%), and mean dose of heart in the CRT plan were all higher than the CRT+IMRT plan, and the differences were statistically significant,t=3.369, 2.393, 2.295, 2.278, 3.129, p=0.008, 0.040, 0.047, 0.049, 0.012.But the V30 (%) of heart in the CRT plan had no statistical difference compared with the CRT+IMRT plan. The V5 (%), V10 (%),V13 (%), and V20 (%) of normal lung in the CRT plan were all higher in the CRT+IMRT plan, and the differences were statistically significant,t=5.435, 3.342, 5.082, 5.153, p=0.001, 0.009, 0.001, 0.001. However, the mean dose and V30 (%) of normal lung in the CRT plan had no statistical differences compared with the CRT+IMRT plan;see Table 4 for details.As for B-P, theV5~50 of B-P in the CRT plan had no statistical differences compared with the CRT+IMRT plan;see Table 4 for details.


### 4.4. CRT Plan versus CRT+ARC Plan

As shown in Table5, the median dose and the Conformity index of PTV in the CRT plan were worse than the CRT+ARC plan, and the differences were statistically significant,t=-2.891, -12.227, p=0.001, 0.018.The other dosimetric parameters of PTV in the CRT plan had no statistical differences compared with the CRT+ARC plan.Table 5
Comparisons of PTV, OAR, and B-P dosimetric parameters between IMRT plan and ARC plan(cGy,x-±s).
Dosimetric parameters CRT plan CRT+ARC plan Difference tvalue Pvalue PTV Minimum dose/cGy 4353.71±69.41 4305.23±114.48 48.48±127.34 1.204 0.259 Maximum dose/cGy 5397.29±82.69 5328.32±58.00 68.97±101.56 2.148 0.060 Median dose/cGy) 5001.56±14.33 5068.44±77.68 -66.88±73.16 -2.891 0.018 Conformity index 0.69±0.05 0.86±0.02 -0.18±0.05 -12.227 0.001 Homogeneity index 0.21±0.02 0.20±0.03 0.00±0.04 0.260 0.801 V105 (%) 15.11±3.64 3.75±9.42 11.36±19.94 1.801 0.105 OAR Spinal cord Maximum dose 3214.23±285.34 2870.81±535.92 343.42±622.22 1.745 0.115 Esophagus V50 (%) 8.49±9.94 17.02±12.75 -8.53±9.27 -2.911 0.017 Maximum dose 5110.67±113.32 5229.34±79.93 -118.67±125.23 -2.997 0.015 Heart V20 (%) 23.77±21.93 20.56±21.20 3.20±3.45 2.933 0.017 V30 (%) 11.98±12.97 14.39±13.89 -2.41±2.16 -3.529 0.006 V40 (%) 6.92±7.43 4.88±4.73 2.05±2.80 2.310 0.046 V45 (%) 5.15±5.48 2.94±2.42 2.21±3.18 2.196 0.056 Mean dose 1061.75±777.82 872.64±788.90 189.11±256.43 2.332 0.045 Normal lung V5 (%) 54.24±8.06 48.77±9.22 5.47±5.55 3.114 0.012 V10 (%) 37.28±8.74 28.30±5.43 8.98±4.48 6.330 0.001 V13 (%) 33.62±7.95 22.40±4.28 11.22±5.32 6.673 0.001 V20 (%) 26.62±7.23 14.74±2.08 11.89±5.94 6.319 0.001 V30 (%) 11.59±1.64 10.36±0.81 1.23±1.56 2.494 0.034 Mean dose 1006.29±522.53 952.15±120.92 54.14±452.68 0.378 0.714 B-P V5(%) 27.31±8.42 25.22±12.40 2.10±14.42 0.460 0.656 V10(%) 18.97±5.53 14.86±6.45 4.11±7.20 1.806 0.104 V15(%) 16.03±4.77 10.13±4.22 5.91±5.02 3.719 0.005 V20(%) 12.49±4.87 7.99±2.65 4.50±4.37 3.261 0.010 V25(%) 7.33±3.41 6.83±1.99 0.50±2.90 0.546 0.598 V30(%) 4.29±2.76 5.33±1.80 -1.03±3.03 -1.077 0.309 V35(%) 2.94±2.29 3.42±1.89 -0.47±2.97 -0.501 0.628 V40(%) 1.95±1.32 1.58±1.71 0.37±2.10 0.560 0.589 V45(%) 1.24±1.06 0.68±1.19 0.57±1.55 1.149 0.280 V50(%) 0.23±0.24 0.12±0.33 0.12±0.39 0.933 0.375As for OARs, the maximum dose of spinal cord in the CRT plan had no statistical differences compared with the CRT+ARC plan.The maximum dose and the V50 (%) of esophagus in the CRT plan was lower than the CRT+ARC plan, and the differences were statistically significant,t=-2.739, -2.911, p=0.023,0.017. The V20 (%), V40 (%), and mean dose of heart in the CRT plan were all higher than the CRT+ARC plan, and the differences were statistically significant,t=2.933, 2.310, 2.332, p=0.017, 0.046, 0.045. But the V30 (%) of heart in the CRT plan was lower than the CRT+ARC plan, and the differences were statistically significant,t=-3.529, p=0.006.The V45 (%) of heart in the CRT plan had no statistical difference compared with the CRT+ARC plan. The V5 (%), V10 (%), V13 (%), V20 (%), and V20 (%) of normal lung in the CRT plan were all higher than the CRT+ARC plan, and the differences were statistically significant,t=3.114, 6.330, 6.673, 6.319, 2.494, p=0.012, 0.001, 0.001, 0.001, 0.034. However, the mean dose of normal lung in the CRT plan had no statistical differences compared with the CRT+ARC plan;see Table 5 for details.As for B-P, the V15 and V20 of B-P in the CRT plan were higher than the CRT+ARC plan, and the differences were statistically significant,t=3.719, 3.261, p=0.005, 0.001. The other dosimetric parameters of B-P in the CRT plan had no statistical differences compared with the CRT+ARC plan;see Table 5 for details.


### 4.5. IMRT Plan versus ARC Plan

As shown in Table6, the minimum dose, the Conformity index, and the Homogeneity index of PTV in the IMRT pan were worse than the ARC plan, and the differences were statistically significant,t=-5.513, -5.381, 4.768, p=0.001, 0.001, 0.001.The other dosimetric parameters of PTV in the CRT plan had no statistical differences compared with the ARC plan.Table 6
Comparisons of PTV, OAR, and B-P dosimetric parameters between IMRT plan and ARC plan(cGy,x-±s).
Dosimetric parameters IMRT plan ARC plan Difference tvalue Pvalue PTV Minimum dose/cGy 3936.34±189.77 4285.12±159.09 -348.78±200.06 -5.513 0.001 Maximum dose/cGy 5350.08±61.15 5348.30±61.22 1.78±50.53 0.111 0.914 Median dose/cGy) 4979.08±77.62 5025.60±6.27 -46.52±78.50 -1.874 0.094 Conformity index 0.80±0.04 0.88±0.02 -0.08±0.05 -5.381 0.001 Homogeneity index 0.28±0.04 0.21±0.04 0.07±0.05 4.768 0.001 V105 (%) 2.92±4.38 0.74±.84 2.18±3.80 1.812 0.103 OAR Spinal cord Maximum dose 2636.20±179.98 2383.08±353.89 253.12±378.72 2.114 0.064 Esophagus V50 (%) 17.79±14.08 19.48±12.51 -1.69±11.39 -0.469 0.650 Maximum dose 5270.17±109.33 4863.6±1253.24 406.55±1182.83 1.087 0.305 Heart V20 (%) 20.78±21.65 13.98±13.25 6.80±8.88 2.423 0.038 V30 (%) 9.83±10.15 6.66±6.03 3.16±4.18 2.391 0.040 V40 (%) 4.87±5.24 3.79±3.21 1.09±2.11 1.628 0.138 V45 (%) 3.59±3.84 2.89±2.45 0.70±1.44 1.530 0.160 Mean dose 932.07±702.92 698.58±652.93 233.48±338.59 2.181 0.057 Normal lung V5 (%) 49.59±6.17 56.06±6.17 -6.47±3.86 -5.309 0.001 V10 (%) 35.13±7.42 36.61±7.24 -1.47±1.72 -2.697 0.025 V13 (%) 30.31±6.38 29.20±6.20 1.12±2.19 1.619 0.140 V20 (%) 22.22±4.48 19.49±3.34 2.73±3.41 2.529 0.032 V30 (%) 8.63±1.47 8.85±0.90 -0.22±1.52 -0.467 0.651 Mean dose 1040.41±147.82 972.39±362.74 68.01±283.07 0.760 0.467 B-P V5(%) 22.91±2.48 26.15±3.14 -3.22±1.64 -6.214 0.001 V10(%) 15.73±2.21 16.54±2.41 -0.81±0.83 -3.055 0.014 V15(%) 12.55±1.83 10.97±1.80 1.57±0.98 5.053 0.001 V20(%) 9.29±1.79 6.46±1.43 2.84±1.04 8.629 0.001 V25(%) 5.19±1.40 3.72±0.93 1.48±0.97 4.816 0.001 V30(%) 2.73±0.81 2.13±0.55 0.60±0.47 3.998 0.003 V35(%) 1.51±0.46 1.22±0.29 0.28±0.32 2.804 0.021 V40(%) 0.71±0.20 0.66±0.14 0.05±0.14 1.172 0.271 V45(%) 0.28±0.10 0.25±0.04 0.04±0.09 1.404 0.194 V50(%) 0.03±0.03 0.00±0.00 0.03±0.02 3.748 0.005As for OARs, the maximum dose of spinal cord, the maximum dose, and the V50 (%) of esophagus in the IMRT plan had no statistical differences compared with the ARC plan. The V20 (%) and V30 (%) of heart in the IMRT plan were all higher than the ARC plan, and the differences were statistically significant,t=2.423, 2.391, p=0.038, 0.040. The V40 (%), the V45 (%), and the mean dose of heart in the IMRT plan had no statistical differences compared with the ARC plan. The V5 (%) and V10 (%) of normal lung in the IMRT plan were lower than the ARC plan, and the differences were statistically significant,t=-5.309, -2.697, p=0.001, 0.025. However, The V20 (%) of normal lung in the IMRT plan were higher than the ARC plan, and the difference was statistically significant,t=2.529, p=0.032.The V13 (%), V30 (%), and the mean dose of normal lung in the IMRT plan had no statistical differences compared with the ARC plan;see Table 6 for details.As for B-P, the V5 and V10 of B-P in the IMRT plan were lower than the ARC plan, and the differences were statistically significant,t=-6.214, -3.055, p=0.001, 0.014. The V15, V20, V25, V30, V35, and V50 of B-P in the IMRT plan were higher than the ARC plan, and the differences were statistically significant,t=5.053, 8.629, 4.816, 3.998, 2.804, 3.748, p=0.001, 0.001, 0.001, 0.003, 0.021, 0.005. The other dosimetric parameters of B-P in the IMRT plan had no statistical differences compared with the ARC plan;see Table 6 for details.


### 4.6. IMRT Plan versus CRT+IMRT Plan

As shown in Table7, all the dosimetric parameters of PTV in the IMRT plan had no statistical differences compared with the CRT+IMRT plan.Table 7
Comparisons of PTV, OAR, and B-P dosimetric parameters between IMRT plan and CRT+IMRT plan(cGy,x-±s).
Dosimetric parameters IMRT plan CRT+IMRT plan Difference tvalue Pvalue PTV Minimum dose/cGy 3936.34±189.77 4051.12±183.68 -114.78±178.63 -2.032 0.073 Maximum dose/cGy 5350.08±61.15 5373.66±103.43 -23.58±112.33 -0.664 0.523 Median dose/cGy) 4979.08±77.62 5017.78±9.25 -38.70±79.38 -1.542 0.158 Conformity index 0.80±0.04 0.80±0.03 0.00±0.05 0.060 0.954 Homogeneity index 0.28±0.04 0.27±0.05 0.01±0.05 1.127 0.289 V105 (%) 2.92±4.38 3.48±5.16 -0.56±6.53 -0.271 0.792 OAR Spinal cord Maximum dose 2636.20±179.98 3181.48±556.33 -545.27±529.43 -3.257 0.010 Esophagus V50 (%) 17.79±14.08 14.68±13.39 3.11±11.78 0.835 0.425 Maximum dose 5270.17±109.33 5205.15±96.40 65.02±104.19 1.973 0.080 Heart V20 (%) 20.78±21.65 20.76±21.46 0.02±2.75 0.029 0.978 V30 (%) 9.83±10.15 13.12±15.14 -3.29±5.38 -1.936 0.085 V40 (%) 4.87±5.24 5.32±5.49 -0.45±0.51 -2.826 0.020 V45 (%) 3.59±3.84 3.86±4.20 -0.26±0.42 -1.993 0.077 Mean dose 932.07±702.92 983.30±742.64 -51.23±83.99 -1.929 0.086 Normal lung V5 (%) 49.59±6.17 46.88±7.19 2.71±3.68 2.325 0.045 V10 (%) 35.13±7.42 31.74±6.64 3.39±4.07 2.635 0.027 V13 (%) 30.31±6.38 24.71±4.66 5.61±3.88 4.569 0.001 V20 (%) 22.22±4.48 17.95±2.56 4.27±3.55 3.806 0.004 V30 (%) 8.63±1.47 11.34±2.11 -2.71±2.34 -3.661 0.005 Mean dose 1040.41±147.82 1001.52±127.12 38.89±57.13 2.153 0.060 B-P V5(%) 22.91±2.48 20.49±2.71 2.43±1.56 4.936 0.001 V10(%) 15.73±2.21 14.32±2.43 1.42±0.83 5.371 0.001 V15(%) 12.55±1.83 11.92±3.92 0.63±3.23 0.616 0.553 V20(%) 9.29±1.79 10.04±3.22 -0.74±2.96 -0.794 0.448 V25(%) 5.19±1.40 8.32±2.76 -3.12±2.66 -3.705 0.005 V30(%) 2.73±0.81 5.76±2.33 -3.03±1.94 -4.924 0.001 V35(%) 1.51±0.46 3.27±1.80 -1.76±1.50 -3.716 0.005 V40(%) 0.71±0.20 1.72±1.46 -1.00±1.36 -2.322 0.045 V45(%) 0.28±0.10 0.87±1.03 -0.58±0.99 -1.857 0.046 V50(%) 0.03±0.03 0.06±0.06 0.03±0.03 -2.369 0.042As for OARs, the maximum dose of spinal cord in the CRT plan was lower than IMRT plan, and the difference was statistically significant,t=-3.257, p=0.010. The maximum dose and the V50 (%) of esophagus in the IMRT plan had no statistical differences compared with the CRT+IMRT plan. The V40 (%) of heart in the IMRT plan was lower than the CRT+IMRT plan, and the difference was statistically significant,t=-2.826, p=0.020. The other dosimetric parameters of heart in the IMRT plan had no statistical differences compared with the CRT+IMRT plan. The V5 (%), V10 (%), V13 (%), V20 (%), and V30 (%) of normal lung in the IMRT plan were lower than the CRT+IMRT plan, and the differences were statistically significant,t=2.325, 2.635, 4.569, 3.806, -3.661, p=0.045, 0.027, 0.001, 0.004, 0.005. However, the V20 (%) of normal lung in the IMRT plan was higher than the CRT+IMRT plan, and the difference was statistically significant,t=2.529, p=0.032. The V13 (%), V30 (%), and the mean dose of normal lung in the IMRT plan had no statistical differences compared with the CRT+IMRT plan,see Table 7 for details.As for B-P, the V5 and V10 of B-P in the IMRT plan were higher than the CRT+IMRT plan, and the differences were statistically significant,t=4.936, 5.371, p=0.001, 0.001. The V25, V30, V35, V40, V45, and V50 of B-P in the IMRT plan were lower than IMRT plan, and the differences were statistically significant,t=-3.705, -4.924, -3.716, -2.322, -1.857, -2.369, p=0.005, 0.001, 0.005, 0.045, 0.046, 0.042. The other dosimetric parameters of B-P in the IMRT plan had no statistical differences compared with the CRT+IMRT plan;see Table 7 for details.


### 4.7. IMRT Plan versus CRT+ARC Plan

As shown in Table8, the minimum dose, the Conformity index, and the Homogeneity index of PTV in the IMRT pan were worse than the CRT+ARC plan, and the differences were statistically significant,t=-6.509, -4.763, 6.611, p=0.001, 0.001, 0.001.The other dosimetric parameters of PTV in the IMRT plan had no statistical differences compared with the CRT+ARC plan.Table 8
Comparisons of PTV, OAR, and B-P dosimetric parameters between IMRT plan and CRT+ARC plancGy,x-±s.
Dosimetric parameters IMRT plan CRT+ARC plan Difference tvalue Pvalue PTV Minimum dose/cGy 3936.34±189.77 4305.23±114.48 -368.89±179.22 -6.509 0.001 Maximum dose/cGy 5350.08±61.15 5328.32±58.00 21.76±62.08 1.108 0.296 Median dose/cGy) 4979.08±77.62 5068.44±77.68 -89.36±127.30 -2.220 0.054 Conformity index 0.80±0.04 0.86±0.02 -0.07±0.05 -4.763 0.001 Homogeneity index 0.28±0.04 0.20±0.03 0.08±0.04 6.611 0.001 V105 (%) 2.92±4.38 3.75±9.42 0.83±11.02 -0.238 0.817 OAR Spinal cord Maximum dose 2636.20±179.98 2870.81±535.92 -234.60±564.83 -3.257 0.222 Esophagus V50 (%) 17.79±14.08 17.02±12.75 0.76±11.38 0.835 0.836 Maximum dose 5270.17±109.33 5229.34±79.93 40.83±113.85 1.973 0.286 Heart V20 (%) 20.78±21.65 20.56±21.20 0.22±2.86 0.029 0.810 V30 (%) 9.83±10.15 14.39±13.89 -4.56±3.99 -1.936 0.006 V40 (%) 4.87±5.24 4.88±4.73 -0.01±0.75 -2.826 0.967 V45 (%) 3.59±3.84 2.94±2.42 0.65±1.51 -1.993 0.205 Mean dose 932.07±702.92 872.64±788.90 59.43±263.06 -1.929 0.493 Normal lung V5 (%) 49.59±6.17 48.77±9.22 0.83±5.61 2.325 0.652 V10 (%) 35.13±7.42 28.30±5.43 6.84±3.23 2.635 0.001 V13 (%) 30.31±6.38 22.40±4.28 7.92±4.03 4.569 0.001 V20 (%) 22.22±4.48 14.74±2.08 7.48±4.17 3.806 0.001 V30 (%) 8.63±1.47 10.36±0.81 -1.72±1.50 -3.661 0.006 Mean dose 1040.41±147.82 952.15±120.92 88.26±69.44 2.153 0.003 B-P V5(%) 22.91±2.48 25.22±12.40 -2.30±12.04 4.936 0.562 V10(%) 15.73±2.21 14.86±6.45 0.87±5.46 5.371 0.626 V15(%) 12.55±1.83 10.13±4.22 2.42±3.23 0.616 0.042 V20(%) 9.29±1.79 7.99±2.65 1.31±1.54 -0.794 0.025 V25(%) 5.19±1.40 6.83±1.99 -1.63±1.09 -3.705 0.001 V30(%) 2.73±0.81 5.33±1.80 -2.60±1.21 -4.924 0.001 V35(%) 1.51±0.46 3.42±1.89 -1.91±1.63 -3.716 0.005 V40(%) 0.71±0.20 1.58±1.71 -0.87±1.56 -2.322 0.112 V45(%) 0.28±0.10 0.68±1.19 -0.38±1.12 -1.857 0.302 V50(%) 0.03±0.03 0.12±0.33 -0.08±0.31 -2.369 0.426As for OARs, the maximum dose of spinal cord, the maximum dose, and the V50 (%) of esophagus in the IMRT plan had no statistical differences compared with the CRT+ARC plan. The V30 (%) of heart in the IMRT plan was lower than the CRT+ARC plan, and the difference was statistically significant,t=-1.936, p=0.006. The other dosimetric parameters of heart in the IMRT plan had no statistical differences compared with the CRT+ARC plan. The V10 (%), V13 (%), V20 (%), V30 (%), and mean dose of normal lung in the IMRT plan were higher than the CRT+ARC plan, and the differences were statistically significant,t=2.635, 4.569, 3.806, -3.661, 2.153, p=0.001, 0.001, 0.001, 0.006, 0.003. But the V5 of normal lung in the IMRT plan had no statistical differences compared with the CRT+ARC plan;see Table 8 for details.As for B-P, the V15, V20, V25, V30, V35, and V50 of B-P in the IMRT plan were higher than the CRT+ARC plan, and the differences were statistically significant,t=0.616, -0.794, -3.705, -4.924,-3.716, p=0.042, 0.025, 0.001, 0.001, 0.005. The other dosimetric parameters of B-P in the IMRT plan had no statistical differences compared with the CRT+ARC plan;see Table 8 for details.


### 4.8. ARC Plan versus CRT+IMRT Plan

As shown in Table9, the minimum dose, the median dose, the conformity index, and the homogeneity index of PTV in the ARC plan were better than the CRT+IMRT plan, and the differences were statistically significant,t=3.861, 2.480, 8.381, -2.795, p=0.004, 0.035, 0.001, 0.021.The other dosimetric parameters of PTV in the ARC plan had no statistical differences compared with the CRT+IMRT plan.Table 9
Comparisons of PTV, OAR, and B-P dosimetric parameters between ARC plan and CRT+IMRT plancGy,x-±s.
Dosimetric parameters ARC plan CRT+IMRT plan Difference tvalue Pvalue PTV Minimum dose/cGy 4285.12±159.09 4051.12±183.68 234.00±191.68 3.861 0.004 Maximum dose/cGy 5348.30±61.22 5373.66±103.43 -25.36±122.01 -0.657 0.527 Median dose/cGy) 5025.60±6.27 5017.78±9.25 7.82±9.97 2.480 0.035 Conformity index 0.88±0.02 0.80±0.03 0.08±0.03 8.381 0.001 Homogeneity index 0.21±0.04 0.27±0.05 -0.05±0.06 -2.795 0.021 V105 (%) 0.74±.84 3.48±5.16 -2.74±5.08 -1.707 0.122 OAR Spinal cord Maximum dose 2383.08±353.89 3181.48±556.33 -798.40±303.74 -8.312 0.001 Esophagus V50 (%) 17.79±14.08 14.68±13.39 4.80±7.56 2.007 0.076 Maximum dose 5270.17±109.33 5205.15±96.40 -341.53±120.23 -0.898 0.392 Heart V20 (%) 20.78±21.65 20.76±21.46 -6.78±8.27 -2.591 0.029 V30 (%) 9.83±10.15 13.12±15.14 -6.46±9.26 -2.205 0.055 V40 (%) 4.87±5.24 5.32±5.49 -1.54±2.34 -2.090 0.066 V45 (%) 3.59±3.84 3.86±4.20 -0.96±1.81 -1.676 0.128 Mean dose 932.07±702.92 983.30±742.64 -284.71±339.66 -2.651 0.026 Normal lung V5 (%) 49.59±6.17 46.88±7.19 9.18±2.45 11.829 0.001 V10 (%) 35.13±7.42 31.74±6.64 4.85±4.05 3.791 0.004 V13 (%) 30.31±6.38 24.71±4.66 4.49±2.86 4.954 0.001 V20 (%) 22.22±4.48 17.95±2.56 1.54±1.52 3.185 0.011 V30 (%) 8.63±1.47 11.34±2.11 -2.49±2.09 -3.761 0.004 Mean dose 1040.41±147.82 1001.52±127.12 -29.12±286.09 -0.322 0.755 B-P V5(%) 26.15±3.14 20.49±2.71 5.66±1.76 10.143 0.001 V10(%) 16.54±2.41 14.32±2.43 2.23±1.03 6.824 0.001 V15(%) 10.97±1.80 11.92±3.92 -0.94±3.24 -0.920 0.382 V20(%) 6.46±1.43 10.04±3.22 -3.58±2.41 -4.684 0.001 V25(%) 3.72±0.93 8.32±2.76 -4.60±2.19 -6.648 0.001 V30(%) 2.13±0.55 5.76±2.33 -3.63±-1.99 -5.754 0.001 V35(%) 1.22±0.29 3.27±1.80 -2.05±1.65 -3.921 0.004 V40(%) 0.66±0.14 1.72±1.46 -1.05±1.39 -2.397 0.040 V45(%) 0.25±0.04 0.87±1.03 -0.62±1.02 -2.136 0.049 V50(%) 0.00±0.0 0.06±0.06 -0.05±0.05 10.143 0.007As for OARs, the maximum dose of spinal cord, the maximum dose and the V50 (%) of esophagus in the ARC plan had no statistical differences compared with the CRT+IMRT plan. The V20 (%) and the median dose of heart in the ARC plan were lower than the CRT+IMRT plan, and the differences were statistically significant,t=-2.591, -2.651, p=0.029, 0.026. The other dosimetric parameters of heart in the ARC plan had no statistical differences compared with the CRT+IMRT plan. The V5 (%), V10 (%), V13 (%), and V20 (%) of normal lung in the ARC plan were higher than the CRT+IMRT plan, and the differences were statistically significant,t=11.829, 3.791, 4.954, 3.185, -3.761, p=0.001, 0.004, 0.001, 0.011, 0.004. But the V30 (%) in the ARC plan was lower than the CRT+IMRT plan, and the difference was statistically significant,t=-3.761, p=0.004. The mean dose of normal lung in the ARC plan had no statistical differences compared with the CRT+IMRT plan;see Table 9 for details.As for B-P, the V5 and V10 of B-P in the ARC plan were higher than the CRT+IMRT plan, and the differences were statistically significant,t=10.143, 6.824, p=0.001, 0.001. However, the V20, V25, V30, V35,V40, V45, and V50 of B-P in the ARC plan were lower than the CRT+IMRT plan, and the differences were statistically significant,t=-4.684, -6.648, -5.754, -3.921, -2.397, -2.136, 10.143, p=0.001, 0.001, 0.001, 0.004, 0.040, 0.049, 0.007. The V15 of B-P in the ARC plan had no statistical differences compared with the CRT+IMRT plan;see Table 9 for details.


### 4.9. ARC Plan versus CRT+ARC Plan

As shown in Table10, the conformity index of PTV in the ARC pan was better than the CRT+ARC plan, and the difference was statistically significant,t=3.500, p=0.007.The other dosimetric parameters of PTV in the ARC plan had no statistical differences compared with the CRT+ARC plan.Table 10
Comparisons of PTV, OAR, and B-P dosimetric parameters between ARC plan and CRT+ARC plancGy,x-±s.
Dosimetric parameters ARC plan CRT+ARC plan Difference tvalue Pvalue PTV Minimum dose/cGy 4285.12±159.09 4305.23±114.48 -20.11±157.12 -0.405 0.695 Maximum dose/cGy 5348.30±61.22 5328.32±58.00 19.98±37.33 1.692 0.125 Median dose/cGy) 5025.60±6.27 5068.44±77.68 -42.84±79.30 -1.708 0.122 Conformity index 0.88±0.02 0.86±0.02 0.01±0.01 3.500 0.007 Homogeneity index 0.21±0.04 0.20±0.03 0.01±0.03 0.633 0.543 V105 (%) 0.74±.84 3.75±9.42 -3.01±9.58 -0.993 0.347 OAR Spinal cord Maximum dose 2383.08±353.89 2870.81±535.92 -487.73±224.92 -6.857 0.001 Esophagus V50 (%) 17.79±14.08 17.02±12.75 2.45±5.72 1.358 0.207 Maximum dose 5270.17±109.33 5229.34±79.93 -365.72±383.31 -0.954 0.365 Heart V20 (%) 20.78±21.65 20.56±21.20 -6.57±8.02 -2.592 0.029 V30 (%) 9.83±10.15 14.39±13.89 -7.72±7.93 -3.080 0.013 V40 (%) 4.87±5.24 4.88±4.73 -1.09±1.58 -2.193 0.056 V45 (%) 3.59±3.84 2.94±2.42 -0.04±0.19 -0.734 0.481 Mean dose 932.07±702.92 872.64±788.90 -174.05±470.84 -1.169 0.272 Normal lung V5 (%) 49.59±6.17 48.77±9.22 7.30±5.31 4.346 0.002 V10 (%) 35.13±7.42 28.30±5.43 8.30±2.97 8.832 0.001 V13 (%) 30.31±6.38 22.40±4.28 6.79±3.67 5.856 0.001 V20 (%) 22.22±4.48 14.74±2.08 4.75±2.39 6.281 0.001 V30 (%) 8.63±1.47 10.36±0.81 -1.50±1.06 -4.461 0.002 Mean dose 1040.41±147.82 952.15±120.92 20.24±91.13 0.222 0.829 B-P V5(%) 26.15±3.14 25.22±12.40 0.93±11.79 0.250 0.808 V10(%) 16.54±2.41 14.86±6.45 1.68±6.01 0.885 0.399 V15(%) 10.97±1.80 10.13±4.22 0.85±3.89 0.692 0.506 V20(%) 6.46±1.43 7.99±2.65 -1.53±2.15 -2.250 0.051 V25(%) 3.72±0.93 6.83±1.99 -3.11±1.51 -6.512 0.001 V30(%) 2.13±0.55 5.33±1.80 -3.19±1.51 -6.645 0.001 V35(%) 1.22±0.29 3.42±1.89 -2.19±1.74 -3.973 0.003 V40(%) 0.66±0.14 1.58±1.71 -0.92±1.65 -1.766 0.111 V45(%) 0.25±0.04 0.68±1.19 -0.43±1.18 -1.147 0.281 V50(%) 0.00±0.0 0.12±0.33 -0.11±0.32 -1.105 0.298As for OARs, the maximum dose of spinal cord in the ARC plan was lower than the CRT+ARC plan, and the difference was statistically significant,t=-6.857, p=0.001. The maximum dose and the V50 (%) of esophagus in the ARC plan had no statistical differences compared with the CRT+ARC plan. The V20 (%) and the V30 (%) of heart in the ARC plan were lower than the CRT+ARC plan, and the differences were statistically significant,t=-2.592, -3.080, p=0.029, 0.013. The other dosimetric parameters of heart in the ARC plan had no statistical differences compared with the CRT+ARC plan. The V5 (%), V10 (%), V13 (%), and V20 (%) of normal lung in the ARC plan were higher than the CRT+ARC plan, and the differences were statistically significant,t=4.346, 8.832, 5.856, 6.281, p=0.002, 0.001, 0.001, 0.001. But the V30 (%) in the ARC plan was lower than the CRT+ARC plan, and the difference was statistically significant,t=-4.461, p=0.002. The mean dose of normal lung in CRT plan had no statistical difference compared with the IMRT plan;see Table 10 for details.As for B-P, the V25, V30, and V35 of B-P in the ARC plan were lower than the CRT+ARC plan, and the differences were statistically significant,t=-6.512,-6.645, -3.973, p=0.001, 0.001, 0.003. The other dosimetric parameters of B-P in the ARC plan had no statistical differences compared with the CRT+ARC plan;see Table 10 for details.


### 4.10. CRT+IMRT Plan versus CRT+ARC Plan

As shown in Table11, the minimum dose, the conformity index, and the homogeneity index of PTV in the CRT+IMRT plan were worse than the CRT+ARC plan, and the differences were statistically significant,t=-6.053, -7.334, 5.364, p=0.001, 0.001, 0.001.The other dosimetric parameters of PTV in the CRT+IMRT plan had no statistical differences compared with the CRT+ARC plan.Table 11
Comparisons of PTV, OAR, and B-P dosimetric parameters between CRT+IMRT plan and CRT+ARC plancGy,x-±s.
Dosimetric parameters CRT+IMRT plan CRT+ARC plan Difference tvalue Pvalue PTV Minimum dose/cGy 4051.12±183.68 4305.23±114.48 -254.11±132.76 -6.053 0.001 Maximum dose/cGy 5373.66±103.43 5328.32±58.00 45.34±115.42 1.242 0.246 Median dose/cGy) 5017.78±9.25 5068.44±77.68 -50.66±74.52 -2.150 0.060 Conformity index 0.80±0.03 0.86±0.02 0.07±0.03 -7.334 0.001 Homogeneity index 0.27±0.05 0.20±0.03 0.06±0.03 5.364 0.001 V105 (%) 3.48±5.16 3.75±9.42 -0.27±11.52 -0.074 0.943 OAR Spinal cord Maximum dose 3181.48±556.33 2870.81±535.92 310.67±262.39 3.744 0.005 Esophagus V50 (%) 14.68±13.39 17.02±12.75 -2.34±4.33 -1.709 0.122 Maximum dose 5205.15±96.40 5229.34±79.93 -24.19±73.44 -1.042 0.325 Heart V20 (%) 20.76±21.46 20.56±21.20 0.20±0.53 1.178 0.269 V30 (%) 13.12±15.14 14.39±13.89 -1.27±2.18 -1.843 0.098 V40 (%) 5.32±5.49 4.88±4.73 0.45±0.88 1.617 0.140 V45 (%) 3.86±4.20 2.94±2.42 0.92±1.88 1.547 0.156 Mean dose 983.30±742.64 872.64±788.90 110.66±322.92 1.084 0.307 Normal lung V5 (%) 46.88±7.19 48.77±9.22 -1.88±5.28 -1.127 0.289 V10 (%) 31.74±6.64 28.30±5.43 3.44±3.07 3.546 0.006 V13 (%) 24.71±4.66 22.40±4.28 2.31±2.17 3.376 0.008 V20 (%) 17.95±2.56 14.74±2.08 3.22±1.45 7.026 0.001 V30 (%) 11.34±2.11 10.36±0.81 0.99±2.04 1.528 0.161 Mean dose 1001.52±127.12 952.15±120.92 49.37±30.51 5.117 0.001 B-P V5(%) 20.49±2.71 25.22±12.40 -4.73±11.15 -1.341 0.213 V10(%) 14.32±2.43 14.86±6.45 -0.54±5.74 -0.300 0.771 V15(%) 11.92±3.92 10.13±4.22 1.79±4.96 1.143 0.283 V20(%) 10.04±3.22 7.99±2.65 2.05±3.37 1.923 0.087 V25(%) 8.32±2.76 6.83±1.99 1.49±2.74 1.715 0.120 V30(%) 5.76±2.33 5.33±1.80 0.43±2.47 0.553 0.594 V35(%) 3.27±1.80 3.42±1.89 -0.15±2.56 -0.186 0.856 V40(%) 1.72±1.46 1.58±1.71 0.13±2.19 0.195 0.850 V45(%) 0.87±1.03 0.68±1.19 0.19±1.57 0.393 0.703 V50(%) 0.06±0.06 0.12±0.33 -0.06±0.32 -0.553 0.594As for OARs, the maximum dose of spinal cord in the CRT+IMRT plan was higher than the CRT+ARC plan, and the difference was statistically significant,t=3.744, p=0.005. The dosimetric parameters of the esophagus and the heart in the CRT+IMRT plan had no statistical differences compared with the CRT+ARC plan. The V10 (%), V13 (%), V20 (%), and the mean dose of normal lung the CRT+IMRT plan were higher than the CRT+ARC plan, and the differences were statistically significant,t=3.546, 3.376, 7.026, p=0.006, 0.008, 0.001. The V30 (%) and the mean dose of normal lung the CRT+IMRT plan had no statistical differences compared with the CRT+ARC plan;see Table 11 for details.As for B-P, all the dosimetric parameters of B-P in the CRT+IMRT plan had no statistical differences compared with the CRT+ARC plan;see Table 11 for details.


## 4.1. CRT Plan versus IMRT Plan

As shown in Table2, the minimum dose of PTV in the CRT pan was better than the IMRT plan, and the difference was statistically significant, t=6.698,p=0.001.However, the Conformity index and V105 (%) of PTV in the CRT plan were worse than the IMRT plan, and the differences were statistically significant, t=-5.367,2.359,p=0.001,0.043.The other dosimetric parameters of PTV in the CRT plan had no statistical differences compared with the IMRT plan.Table 2
Comparisons of PTV, OAR, and B-P dosimetric parameters between CRT plan and IMRT plan (cGy,x-±s).
Dosimetric parameters CRT plan IMRT plan Difference t value P value PTV Minimum dose/cGy 4353.71±69.41 3936.34±189.77 417.37±197.05 6.698 0.001 Maximum dose/cGy 5397.29±82.69 5350.08±61.15 47.21±108.72 1.373 0.203 Median dose/cGy) 5001.56±14.33 4979.08±77.62 22.48±81.23 0.875 0.404 Conformity index 0.69±0.05 0.80±0.04 -0.11±0.06 -5.367 0.001 Homogeneity index 0.21±0.02 0.28±0.04 -0.00±0.03 -0.330 0.749 V105 (%) 15.11±3.64 2.92±4.38 12.19±16.34 2.359 0.043 OAR Spinal cord Maximum dose 3214.23±285.34 2636.20±179.98 578.02±259.87 7.034 0.001 Esophagus V50 (%) 8.49±9.94 17.79±14.08 -9.30±16.53 -1.778 0.109 Maximum dose 5110.67±113.32 5270.17±109.33 -159.50±132.28 -3.813 0.004 Heart V20 (%) 23.77±21.93 20.78±21.65 2.97±1.75 5.382 0.001 V30 (%) 11.98±12.97 9.83±10.15 2.15±3.10 2.191 0.056 V40 (%) 6.92±7.43 4.87±5.24 2.05±2.26 2.864 0.019 V45 (%) 5.15±5.48 3.59±3.84 1.55±1.73 2.832 0.020 Mean dose 1061.75±777.82 932.07±702.92 129.68±83.46 4.913 0.001 Normal lung V5 (%) 54.24±8.06 49.59±6.17 4.64±2.27 6.456 0.001 V10 (%) 37.28±8.74 35.13±7.42 2.14±2.55 2.653 0.026 V13 (%) 33.62±7.95 30.31±6.38 3.29±2.25 4.636 0.001 V20 (%) 26.62±7.23 22.22±4.48 4.40±2.32 5.982 0.001 V30 (%) 11.59±1.64 8.63±1.47 2.95±1.38 6.771 0.001 Mean dose 1006.29±522.53 1040.41±147.82 -34.12±418.64 -0.258 0.802 B-P V5(%) 27.31±8.42 22.91±2.48 4.39±7.40 1.879 0.093 V10(%) 18.97±5.53 15.73±2.21 3.24±4.37 2.347 0.044 V15(%) 16.03±4.77 12.55±1.83 3.48±3.84 2.870 0.018 V20(%) 12.49±4.87 9.29±1.79 3.19±4.28 2.363 0.042 V25(%) 7.33±3.41 5.19±1.40 2.13±3.05 2.216 0.054 V30(%) 4.29±2.76 2.73±0.81 1.56±2.45 2.015 0.075 V35(%) 2.94±2.29 1.51±0.46 1.44±1.97 2.317 0.046 V40(%) 1.95±1.32 0.71±0.20 1.24±1.23 3.181 0.011 V45(%) 1.24±1.06 0.28±0.10 0.95±1.01 2.957 0.016 V50(%) 0.23±0.24 0.03±0.03 0.19±.22 2.771 0.022As for OARs, V50 (%) of esophagus, V30 (%) of heart, and the mean dose of normal lung in the CRT plan had no statistical differences compared with the IMRT plan. The maximum dose of spinal cord in the CRT plan was higher than the IMRT plan, and the difference was statistically significant, t=7.034, p=0.001.The maximum dose of esophagus was lower than the IMRT plan, and the difference was statistically significant, t=-3.813, p=0.004. The V20 (%), V40 (%), V45 (%), and mean dose of heart in the CRT plan were all higher than the IMRT plan, and the differences were statistically significant, t=5.382,2.864,2.832,4.913, p=0.001,0.019,0.020,0.001. The V5 (%), V10 (%), V13 (%), V20 (%), and V30 (%) of normal lung in the CRT plan were all higher than the IMRT plan, and the differences were statistically significant, t=6.456,2.653,4.636,5.982,6.771, p=0.001,0.026,0.001,0.001,0.001; see Table 2 for details.As for B-P, theV5~50 of B-P in the CRT plan were all higher than the IMRT plan, and the differences were not statistically significant for V5, V25, and V30, but the differences were statistically significant for V10, V15, V20, V35, V40, V45, V50,t=2.347, 2.870, 2.363, 2.317, 3.181, 2.957, 2.771, p=0.044,0.018,0.042,0.046,0.011,0.016,0.022;see Table 2 for details.


## 4.2. CRT Plan versus ARC Plan

As shown in Table3, the median dose, the Conformity index, and V105 (%) of PTV in the CRT pan were worse than the ARC plan, and the differences were statistically significant,t=-4.433, -15.148, 2.766, p=0.002, 0.001, 0.022.The other dosimetric parameters of PTV in the CRT plan had no statistical differences compared with the ARC plan.Table 3
Comparisons of PTV, OAR, and B-P dosimetric parameters between CRT plan and ARC plan(cGy,x-±s).
Dosimetric parameters CRT plan ARC plan Difference tvalue Pvalue PTV Minimum dose/cGy 4353.71±69.41 4285.12±159.09 68.59±165.02 1.314 0.221 Maximum dose/cGy 5397.29±82.69 5348.30±61.22 48.99±100.59 1.540 0.158 Median dose/cGy) 5001.56±14.33 5025.60±6.27 -24.04±17.14 -4.433 0.002 Conformity index 0.69±0.05 0.88±0.02 -0.19±0.04 -15.148 0.001 Homogeneity index 0.21±0.02 0.21±0.04 -0.00±0.04 -0.330 0.749 V105 (%) 15.11±3.64 0.74±.84 14.37±16.43 2.766 0.022 OAR Spinal cord Maximum dose 3214.23±285.34 2383.08±353.89 831.15±476.47 5.516 0.001 Esophagus V50 (%) 8.49±9.94 19.48±12.51 -10.99±8.11 -4.286 0.002 Maximum dose 5110.67±113.32 4863.6±1253.24 -611.56±1105.668 0.651 0.531 Heart V20 (%) 23.77±21.93 13.98±13.25 3.21±16.34 3.369 0.008 V30 (%) 11.98±12.97 6.66±6.03 0.29±10.33 2.393 0.040 V40 (%) 6.92±7.43 3.79±3.21 0.04±6.23 2.295 0.047 V45 (%) 5.15±5.48 2.89±2.45 0.01±4.49 2.278 0.049 Mean dose 1061.75±777.82 698.58±652.93 100.58±625.75 3.129 0.012 Normal lung V5 (%) 54.24±8.06 56.06±6.17 -5.33±1.66 -1.186 0.266 V10 (%) 37.28±8.74 36.61±7.24 -1.71±3.07 0.643 0.536 V13 (%) 33.62±7.95 29.20±6.20 1.82±7.01 3.860 0.004 V20 (%) 26.62±7.23 19.49±3.34 3.59±10.68 4.551 0.001 V30 (%) 11.59±1.64 8.85±0.90 1.55±3.91 5.244 0.001 Mean dose 1006.29±522.53 972.39±362.74 -344.47±412.264 0.203 0.844 B-P V5(%) 27.31±8.42 26.15±3.14 -3.97±6.30 0.514 0.619 V10(%) 18.97±5.53 16.54±2.41 -0.86±5.72 1.667 0.130 V15(%) 16.03±4.77 10.97±1.80 2.28±7.82 4.121 0.003 V20(%) 12.49±4.87 6.46±1.43 3.22±8.84 4.861 0.001 V25(%) 7.33±3.41 3.72±0.93 1.64±5.58 4.142 0.003 V30(%) 4.29±2.76 2.13±0.55 0.39±3.92 2.774 0.022 V35(%) 2.94±2.29 1.22±0.29 0.18±3.27 2.532 0.032 V40(%) 1.95±1.32 0.66±0.14 0.39±2.19 3.244 0.010 V45(%) 1.24±1.06 0.25±0.04 0.24±1.74 2.999 0.015 V50(%) 0.23±0.24 0.00±0.00 0.01±0.05 3.748 0.005As for OARs, the maximum dose of spinal cord in the CRT plan was higher than the ARC plan, and the difference was statistically significant,t=5.516, p=0.001.The V50 (%) of esophagus was lower than the ARC plan, and the difference was statistically significant,t=-4.286, p=0.002. But the maximum dose of esophagus in the CRT plan had no statistical differences compared with the ARC plan. The V20 (%), V30 (%), V40 (%), V45 (%), and mean dose of heart in the CRT plan were all higher than the ARC plan, and the differences were statistically significant,t=3.369, 2.393, 2.295, 2.278, 3.129, p=0.008, 0.040, 0.047, 0.049, 0.012.The V5 (%), V10 (%), and mean dose of normal lung in the CRT plan had no statistical differences compared with the ARC plan. However, the V13 (%), V20 (%), and V30 (%) of normal lung in the CRT plan were all higher than the ARC plan, and the differences were statistically significant,t=3.860, 4.551, 5.244, p=0.004, 0.001, 0.001;see Table 3 for details.As for B-P, theV5~50 of B-P in the CRT plan were all higher than the ARC plan, and the differences were not statistically significant for V5, and V10, but the differences were statistically significant for V15, V20, V30, V35, V40, V45, V50,t=4.121, 4.861, 4.142, 2.774, 2.532, 3.244, 2.999, 3.748, p=0.003, 0.001, 0.003, 0.022, 0.032, 0.010, 0.015, 0.005;see Table 3 for details.


## 4.3. CRT Plan versus CRT+IMRT Plan

As shown in Table4, the median dose and the Conformity index of PTV in the CRT pan were worse than the CRT+IMRT plan, and the differences were statistically significant,t=-2.604, -7.910, p=0.001, 0.015.The other dosimetric parameters of PTV in the CRT plan had no statistical differences compared with the IMRT plan.Table 4
Comparisons of PTV, OAR, and B-P dosimetric parameters between CRT plan and CRT+IMRT plan(cGy,x-±s).
Dosimetric parameters CRT plan CRT+IMRT plan Difference tvalue Pvalue PTV Minimum dose/cGy 4353.71±69.41 4051.12±183.68 302.59±62.84 4.815 0.001 Maximum dose/cGy 5397.29±82.69 5373.66±103.43 23.63±50.75 0.466 0.653 Median dose/cGy) 5001.56±14.33 5017.78±9.25 -16.22±6.23 -2.604 0.029 Conformity index 0.69±0.05 0.80±0.03 -0.11±0.04 -7.910 0.001 Homogeneity index 0.21±0.02 0.27±0.05 -0.06±0.06 -3.006 0.015 V105 (%) 15.11±3.64 3.48±5.16 11.63±19.11 1.924 0.086 OAR Spinal cord Maximum dose 3214.23±285.34 3181.48±556.33 32.75±188.93 0.173 0.866 Esophagus V50 (%) 8.49±9.94 14.68±13.39 -6.19±10.77 -1.817 0.103 Maximum dose 5110.67±113.32 5205.15±96.40 -94.48±109.08 -2.739 0.023 Heart V20 (%) 23.77±21.93 20.76±21.46 3.00±3.26 2.913 0.017 V30 (%) 11.98±12.97 13.12±15.14 -1.14±2.68 -1.347 0.211 V40 (%) 6.92±7.43 5.32±5.49 1.60±2.11 2.391 0.041 V45 (%) 5.15±5.48 3.86±4.20 1.29±1.36 2.996 0.015 Mean dose 1061.75±777.82 983.30±742.64 78.45±83.12 2.985 0.015 Normal lung V5 (%) 54.24±8.06 46.88±7.19 7.35±4.28 5.435 0.001 V10 (%) 37.28±8.74 31.74±6.64 5.54±5.24 3.342 0.009 V13 (%) 33.62±7.95 24.71±4.66 8.90±5.54 5.082 0.001 V20 (%) 26.62±7.23 17.95±2.56 8.67±5.32 5.153 0.001 V30 (%) 11.59±1.64 11.34±2.11 0.24±1.68 0.457 0.659 Mean dose 1006.29±522.53 1001.52±127.12 4.77±447.35 0.034 0.974 B-P V5(%) 27.31±8.42 20.49±2.71 6.83±7.07 3.053 0.014 V10(%) 18.97±5.53 14.32±2.43 4.65±3.90 3.780 0.004 V15(%) 16.03±4.77 11.92±3.92 4.11±1.13 11.481 0.001 V20(%) 12.49±4.87 10.04±3.22 2.45±1.81 4.287 0.002 V25(%) 7.33±3.41 8.32±2.76 -0.98±1.56 -1.992 0.078 V30(%) 4.29±2.76 5.76±2.33 -1.47±1.16 -3.967 0.003 V35(%) 2.94±2.29 3.27±1.80 -0.32±0.78 -1.282 0.232 V40(%) 1.95±1.32 1.72±1.46 0.24±0.24 3.209 0.011 V45(%) 1.24±1.06 0.87±1.03 0.37±0.12 9.582 0.001 V50(%) 0.23±0.24 0.06±0.06 0.17±0.20 2.730 0.023As for OARs, the maximum dose of spinal cord in the CRT plan had no statistical difference compared with the CRT+IMRT plan.The maximum dose of esophagus was lower in the CRT plan than the CRT+IMRT plan, and the difference was statistically significant,t=-2.739, p=0.023. But the V50 (%) of esophagus in the CRT plan had no statistical difference compared with the CRT+IMRT plan. The V20 (%), V40 (%), V45 (%), and mean dose of heart in the CRT plan were all higher than the CRT+IMRT plan, and the differences were statistically significant,t=3.369, 2.393, 2.295, 2.278, 3.129, p=0.008, 0.040, 0.047, 0.049, 0.012.But the V30 (%) of heart in the CRT plan had no statistical difference compared with the CRT+IMRT plan. The V5 (%), V10 (%),V13 (%), and V20 (%) of normal lung in the CRT plan were all higher in the CRT+IMRT plan, and the differences were statistically significant,t=5.435, 3.342, 5.082, 5.153, p=0.001, 0.009, 0.001, 0.001. However, the mean dose and V30 (%) of normal lung in the CRT plan had no statistical differences compared with the CRT+IMRT plan;see Table 4 for details.As for B-P, theV5~50 of B-P in the CRT plan had no statistical differences compared with the CRT+IMRT plan;see Table 4 for details.


## 4.4. CRT Plan versus CRT+ARC Plan

As shown in Table5, the median dose and the Conformity index of PTV in the CRT plan were worse than the CRT+ARC plan, and the differences were statistically significant,t=-2.891, -12.227, p=0.001, 0.018.The other dosimetric parameters of PTV in the CRT plan had no statistical differences compared with the CRT+ARC plan.Table 5
Comparisons of PTV, OAR, and B-P dosimetric parameters between IMRT plan and ARC plan(cGy,x-±s).
Dosimetric parameters CRT plan CRT+ARC plan Difference tvalue Pvalue PTV Minimum dose/cGy 4353.71±69.41 4305.23±114.48 48.48±127.34 1.204 0.259 Maximum dose/cGy 5397.29±82.69 5328.32±58.00 68.97±101.56 2.148 0.060 Median dose/cGy) 5001.56±14.33 5068.44±77.68 -66.88±73.16 -2.891 0.018 Conformity index 0.69±0.05 0.86±0.02 -0.18±0.05 -12.227 0.001 Homogeneity index 0.21±0.02 0.20±0.03 0.00±0.04 0.260 0.801 V105 (%) 15.11±3.64 3.75±9.42 11.36±19.94 1.801 0.105 OAR Spinal cord Maximum dose 3214.23±285.34 2870.81±535.92 343.42±622.22 1.745 0.115 Esophagus V50 (%) 8.49±9.94 17.02±12.75 -8.53±9.27 -2.911 0.017 Maximum dose 5110.67±113.32 5229.34±79.93 -118.67±125.23 -2.997 0.015 Heart V20 (%) 23.77±21.93 20.56±21.20 3.20±3.45 2.933 0.017 V30 (%) 11.98±12.97 14.39±13.89 -2.41±2.16 -3.529 0.006 V40 (%) 6.92±7.43 4.88±4.73 2.05±2.80 2.310 0.046 V45 (%) 5.15±5.48 2.94±2.42 2.21±3.18 2.196 0.056 Mean dose 1061.75±777.82 872.64±788.90 189.11±256.43 2.332 0.045 Normal lung V5 (%) 54.24±8.06 48.77±9.22 5.47±5.55 3.114 0.012 V10 (%) 37.28±8.74 28.30±5.43 8.98±4.48 6.330 0.001 V13 (%) 33.62±7.95 22.40±4.28 11.22±5.32 6.673 0.001 V20 (%) 26.62±7.23 14.74±2.08 11.89±5.94 6.319 0.001 V30 (%) 11.59±1.64 10.36±0.81 1.23±1.56 2.494 0.034 Mean dose 1006.29±522.53 952.15±120.92 54.14±452.68 0.378 0.714 B-P V5(%) 27.31±8.42 25.22±12.40 2.10±14.42 0.460 0.656 V10(%) 18.97±5.53 14.86±6.45 4.11±7.20 1.806 0.104 V15(%) 16.03±4.77 10.13±4.22 5.91±5.02 3.719 0.005 V20(%) 12.49±4.87 7.99±2.65 4.50±4.37 3.261 0.010 V25(%) 7.33±3.41 6.83±1.99 0.50±2.90 0.546 0.598 V30(%) 4.29±2.76 5.33±1.80 -1.03±3.03 -1.077 0.309 V35(%) 2.94±2.29 3.42±1.89 -0.47±2.97 -0.501 0.628 V40(%) 1.95±1.32 1.58±1.71 0.37±2.10 0.560 0.589 V45(%) 1.24±1.06 0.68±1.19 0.57±1.55 1.149 0.280 V50(%) 0.23±0.24 0.12±0.33 0.12±0.39 0.933 0.375As for OARs, the maximum dose of spinal cord in the CRT plan had no statistical differences compared with the CRT+ARC plan.The maximum dose and the V50 (%) of esophagus in the CRT plan was lower than the CRT+ARC plan, and the differences were statistically significant,t=-2.739, -2.911, p=0.023,0.017. The V20 (%), V40 (%), and mean dose of heart in the CRT plan were all higher than the CRT+ARC plan, and the differences were statistically significant,t=2.933, 2.310, 2.332, p=0.017, 0.046, 0.045. But the V30 (%) of heart in the CRT plan was lower than the CRT+ARC plan, and the differences were statistically significant,t=-3.529, p=0.006.The V45 (%) of heart in the CRT plan had no statistical difference compared with the CRT+ARC plan. The V5 (%), V10 (%), V13 (%), V20 (%), and V20 (%) of normal lung in the CRT plan were all higher than the CRT+ARC plan, and the differences were statistically significant,t=3.114, 6.330, 6.673, 6.319, 2.494, p=0.012, 0.001, 0.001, 0.001, 0.034. However, the mean dose of normal lung in the CRT plan had no statistical differences compared with the CRT+ARC plan;see Table 5 for details.As for B-P, the V15 and V20 of B-P in the CRT plan were higher than the CRT+ARC plan, and the differences were statistically significant,t=3.719, 3.261, p=0.005, 0.001. The other dosimetric parameters of B-P in the CRT plan had no statistical differences compared with the CRT+ARC plan;see Table 5 for details.


## 4.5. IMRT Plan versus ARC Plan

As shown in Table6, the minimum dose, the Conformity index, and the Homogeneity index of PTV in the IMRT pan were worse than the ARC plan, and the differences were statistically significant,t=-5.513, -5.381, 4.768, p=0.001, 0.001, 0.001.The other dosimetric parameters of PTV in the CRT plan had no statistical differences compared with the ARC plan.Table 6
Comparisons of PTV, OAR, and B-P dosimetric parameters between IMRT plan and ARC plan(cGy,x-±s).
Dosimetric parameters IMRT plan ARC plan Difference tvalue Pvalue PTV Minimum dose/cGy 3936.34±189.77 4285.12±159.09 -348.78±200.06 -5.513 0.001 Maximum dose/cGy 5350.08±61.15 5348.30±61.22 1.78±50.53 0.111 0.914 Median dose/cGy) 4979.08±77.62 5025.60±6.27 -46.52±78.50 -1.874 0.094 Conformity index 0.80±0.04 0.88±0.02 -0.08±0.05 -5.381 0.001 Homogeneity index 0.28±0.04 0.21±0.04 0.07±0.05 4.768 0.001 V105 (%) 2.92±4.38 0.74±.84 2.18±3.80 1.812 0.103 OAR Spinal cord Maximum dose 2636.20±179.98 2383.08±353.89 253.12±378.72 2.114 0.064 Esophagus V50 (%) 17.79±14.08 19.48±12.51 -1.69±11.39 -0.469 0.650 Maximum dose 5270.17±109.33 4863.6±1253.24 406.55±1182.83 1.087 0.305 Heart V20 (%) 20.78±21.65 13.98±13.25 6.80±8.88 2.423 0.038 V30 (%) 9.83±10.15 6.66±6.03 3.16±4.18 2.391 0.040 V40 (%) 4.87±5.24 3.79±3.21 1.09±2.11 1.628 0.138 V45 (%) 3.59±3.84 2.89±2.45 0.70±1.44 1.530 0.160 Mean dose 932.07±702.92 698.58±652.93 233.48±338.59 2.181 0.057 Normal lung V5 (%) 49.59±6.17 56.06±6.17 -6.47±3.86 -5.309 0.001 V10 (%) 35.13±7.42 36.61±7.24 -1.47±1.72 -2.697 0.025 V13 (%) 30.31±6.38 29.20±6.20 1.12±2.19 1.619 0.140 V20 (%) 22.22±4.48 19.49±3.34 2.73±3.41 2.529 0.032 V30 (%) 8.63±1.47 8.85±0.90 -0.22±1.52 -0.467 0.651 Mean dose 1040.41±147.82 972.39±362.74 68.01±283.07 0.760 0.467 B-P V5(%) 22.91±2.48 26.15±3.14 -3.22±1.64 -6.214 0.001 V10(%) 15.73±2.21 16.54±2.41 -0.81±0.83 -3.055 0.014 V15(%) 12.55±1.83 10.97±1.80 1.57±0.98 5.053 0.001 V20(%) 9.29±1.79 6.46±1.43 2.84±1.04 8.629 0.001 V25(%) 5.19±1.40 3.72±0.93 1.48±0.97 4.816 0.001 V30(%) 2.73±0.81 2.13±0.55 0.60±0.47 3.998 0.003 V35(%) 1.51±0.46 1.22±0.29 0.28±0.32 2.804 0.021 V40(%) 0.71±0.20 0.66±0.14 0.05±0.14 1.172 0.271 V45(%) 0.28±0.10 0.25±0.04 0.04±0.09 1.404 0.194 V50(%) 0.03±0.03 0.00±0.00 0.03±0.02 3.748 0.005As for OARs, the maximum dose of spinal cord, the maximum dose, and the V50 (%) of esophagus in the IMRT plan had no statistical differences compared with the ARC plan. The V20 (%) and V30 (%) of heart in the IMRT plan were all higher than the ARC plan, and the differences were statistically significant,t=2.423, 2.391, p=0.038, 0.040. The V40 (%), the V45 (%), and the mean dose of heart in the IMRT plan had no statistical differences compared with the ARC plan. The V5 (%) and V10 (%) of normal lung in the IMRT plan were lower than the ARC plan, and the differences were statistically significant,t=-5.309, -2.697, p=0.001, 0.025. However, The V20 (%) of normal lung in the IMRT plan were higher than the ARC plan, and the difference was statistically significant,t=2.529, p=0.032.The V13 (%), V30 (%), and the mean dose of normal lung in the IMRT plan had no statistical differences compared with the ARC plan;see Table 6 for details.As for B-P, the V5 and V10 of B-P in the IMRT plan were lower than the ARC plan, and the differences were statistically significant,t=-6.214, -3.055, p=0.001, 0.014. The V15, V20, V25, V30, V35, and V50 of B-P in the IMRT plan were higher than the ARC plan, and the differences were statistically significant,t=5.053, 8.629, 4.816, 3.998, 2.804, 3.748, p=0.001, 0.001, 0.001, 0.003, 0.021, 0.005. The other dosimetric parameters of B-P in the IMRT plan had no statistical differences compared with the ARC plan;see Table 6 for details.


## 4.6. IMRT Plan versus CRT+IMRT Plan

As shown in Table7, all the dosimetric parameters of PTV in the IMRT plan had no statistical differences compared with the CRT+IMRT plan.Table 7
Comparisons of PTV, OAR, and B-P dosimetric parameters between IMRT plan and CRT+IMRT plan(cGy,x-±s).
Dosimetric parameters IMRT plan CRT+IMRT plan Difference tvalue Pvalue PTV Minimum dose/cGy 3936.34±189.77 4051.12±183.68 -114.78±178.63 -2.032 0.073 Maximum dose/cGy 5350.08±61.15 5373.66±103.43 -23.58±112.33 -0.664 0.523 Median dose/cGy) 4979.08±77.62 5017.78±9.25 -38.70±79.38 -1.542 0.158 Conformity index 0.80±0.04 0.80±0.03 0.00±0.05 0.060 0.954 Homogeneity index 0.28±0.04 0.27±0.05 0.01±0.05 1.127 0.289 V105 (%) 2.92±4.38 3.48±5.16 -0.56±6.53 -0.271 0.792 OAR Spinal cord Maximum dose 2636.20±179.98 3181.48±556.33 -545.27±529.43 -3.257 0.010 Esophagus V50 (%) 17.79±14.08 14.68±13.39 3.11±11.78 0.835 0.425 Maximum dose 5270.17±109.33 5205.15±96.40 65.02±104.19 1.973 0.080 Heart V20 (%) 20.78±21.65 20.76±21.46 0.02±2.75 0.029 0.978 V30 (%) 9.83±10.15 13.12±15.14 -3.29±5.38 -1.936 0.085 V40 (%) 4.87±5.24 5.32±5.49 -0.45±0.51 -2.826 0.020 V45 (%) 3.59±3.84 3.86±4.20 -0.26±0.42 -1.993 0.077 Mean dose 932.07±702.92 983.30±742.64 -51.23±83.99 -1.929 0.086 Normal lung V5 (%) 49.59±6.17 46.88±7.19 2.71±3.68 2.325 0.045 V10 (%) 35.13±7.42 31.74±6.64 3.39±4.07 2.635 0.027 V13 (%) 30.31±6.38 24.71±4.66 5.61±3.88 4.569 0.001 V20 (%) 22.22±4.48 17.95±2.56 4.27±3.55 3.806 0.004 V30 (%) 8.63±1.47 11.34±2.11 -2.71±2.34 -3.661 0.005 Mean dose 1040.41±147.82 1001.52±127.12 38.89±57.13 2.153 0.060 B-P V5(%) 22.91±2.48 20.49±2.71 2.43±1.56 4.936 0.001 V10(%) 15.73±2.21 14.32±2.43 1.42±0.83 5.371 0.001 V15(%) 12.55±1.83 11.92±3.92 0.63±3.23 0.616 0.553 V20(%) 9.29±1.79 10.04±3.22 -0.74±2.96 -0.794 0.448 V25(%) 5.19±1.40 8.32±2.76 -3.12±2.66 -3.705 0.005 V30(%) 2.73±0.81 5.76±2.33 -3.03±1.94 -4.924 0.001 V35(%) 1.51±0.46 3.27±1.80 -1.76±1.50 -3.716 0.005 V40(%) 0.71±0.20 1.72±1.46 -1.00±1.36 -2.322 0.045 V45(%) 0.28±0.10 0.87±1.03 -0.58±0.99 -1.857 0.046 V50(%) 0.03±0.03 0.06±0.06 0.03±0.03 -2.369 0.042As for OARs, the maximum dose of spinal cord in the CRT plan was lower than IMRT plan, and the difference was statistically significant,t=-3.257, p=0.010. The maximum dose and the V50 (%) of esophagus in the IMRT plan had no statistical differences compared with the CRT+IMRT plan. The V40 (%) of heart in the IMRT plan was lower than the CRT+IMRT plan, and the difference was statistically significant,t=-2.826, p=0.020. The other dosimetric parameters of heart in the IMRT plan had no statistical differences compared with the CRT+IMRT plan. The V5 (%), V10 (%), V13 (%), V20 (%), and V30 (%) of normal lung in the IMRT plan were lower than the CRT+IMRT plan, and the differences were statistically significant,t=2.325, 2.635, 4.569, 3.806, -3.661, p=0.045, 0.027, 0.001, 0.004, 0.005. However, the V20 (%) of normal lung in the IMRT plan was higher than the CRT+IMRT plan, and the difference was statistically significant,t=2.529, p=0.032. The V13 (%), V30 (%), and the mean dose of normal lung in the IMRT plan had no statistical differences compared with the CRT+IMRT plan,see Table 7 for details.As for B-P, the V5 and V10 of B-P in the IMRT plan were higher than the CRT+IMRT plan, and the differences were statistically significant,t=4.936, 5.371, p=0.001, 0.001. The V25, V30, V35, V40, V45, and V50 of B-P in the IMRT plan were lower than IMRT plan, and the differences were statistically significant,t=-3.705, -4.924, -3.716, -2.322, -1.857, -2.369, p=0.005, 0.001, 0.005, 0.045, 0.046, 0.042. The other dosimetric parameters of B-P in the IMRT plan had no statistical differences compared with the CRT+IMRT plan;see Table 7 for details.


## 4.7. IMRT Plan versus CRT+ARC Plan

As shown in Table8, the minimum dose, the Conformity index, and the Homogeneity index of PTV in the IMRT pan were worse than the CRT+ARC plan, and the differences were statistically significant,t=-6.509, -4.763, 6.611, p=0.001, 0.001, 0.001.The other dosimetric parameters of PTV in the IMRT plan had no statistical differences compared with the CRT+ARC plan.Table 8
Comparisons of PTV, OAR, and B-P dosimetric parameters between IMRT plan and CRT+ARC plancGy,x-±s.
Dosimetric parameters IMRT plan CRT+ARC plan Difference tvalue Pvalue PTV Minimum dose/cGy 3936.34±189.77 4305.23±114.48 -368.89±179.22 -6.509 0.001 Maximum dose/cGy 5350.08±61.15 5328.32±58.00 21.76±62.08 1.108 0.296 Median dose/cGy) 4979.08±77.62 5068.44±77.68 -89.36±127.30 -2.220 0.054 Conformity index 0.80±0.04 0.86±0.02 -0.07±0.05 -4.763 0.001 Homogeneity index 0.28±0.04 0.20±0.03 0.08±0.04 6.611 0.001 V105 (%) 2.92±4.38 3.75±9.42 0.83±11.02 -0.238 0.817 OAR Spinal cord Maximum dose 2636.20±179.98 2870.81±535.92 -234.60±564.83 -3.257 0.222 Esophagus V50 (%) 17.79±14.08 17.02±12.75 0.76±11.38 0.835 0.836 Maximum dose 5270.17±109.33 5229.34±79.93 40.83±113.85 1.973 0.286 Heart V20 (%) 20.78±21.65 20.56±21.20 0.22±2.86 0.029 0.810 V30 (%) 9.83±10.15 14.39±13.89 -4.56±3.99 -1.936 0.006 V40 (%) 4.87±5.24 4.88±4.73 -0.01±0.75 -2.826 0.967 V45 (%) 3.59±3.84 2.94±2.42 0.65±1.51 -1.993 0.205 Mean dose 932.07±702.92 872.64±788.90 59.43±263.06 -1.929 0.493 Normal lung V5 (%) 49.59±6.17 48.77±9.22 0.83±5.61 2.325 0.652 V10 (%) 35.13±7.42 28.30±5.43 6.84±3.23 2.635 0.001 V13 (%) 30.31±6.38 22.40±4.28 7.92±4.03 4.569 0.001 V20 (%) 22.22±4.48 14.74±2.08 7.48±4.17 3.806 0.001 V30 (%) 8.63±1.47 10.36±0.81 -1.72±1.50 -3.661 0.006 Mean dose 1040.41±147.82 952.15±120.92 88.26±69.44 2.153 0.003 B-P V5(%) 22.91±2.48 25.22±12.40 -2.30±12.04 4.936 0.562 V10(%) 15.73±2.21 14.86±6.45 0.87±5.46 5.371 0.626 V15(%) 12.55±1.83 10.13±4.22 2.42±3.23 0.616 0.042 V20(%) 9.29±1.79 7.99±2.65 1.31±1.54 -0.794 0.025 V25(%) 5.19±1.40 6.83±1.99 -1.63±1.09 -3.705 0.001 V30(%) 2.73±0.81 5.33±1.80 -2.60±1.21 -4.924 0.001 V35(%) 1.51±0.46 3.42±1.89 -1.91±1.63 -3.716 0.005 V40(%) 0.71±0.20 1.58±1.71 -0.87±1.56 -2.322 0.112 V45(%) 0.28±0.10 0.68±1.19 -0.38±1.12 -1.857 0.302 V50(%) 0.03±0.03 0.12±0.33 -0.08±0.31 -2.369 0.426As for OARs, the maximum dose of spinal cord, the maximum dose, and the V50 (%) of esophagus in the IMRT plan had no statistical differences compared with the CRT+ARC plan. The V30 (%) of heart in the IMRT plan was lower than the CRT+ARC plan, and the difference was statistically significant,t=-1.936, p=0.006. The other dosimetric parameters of heart in the IMRT plan had no statistical differences compared with the CRT+ARC plan. The V10 (%), V13 (%), V20 (%), V30 (%), and mean dose of normal lung in the IMRT plan were higher than the CRT+ARC plan, and the differences were statistically significant,t=2.635, 4.569, 3.806, -3.661, 2.153, p=0.001, 0.001, 0.001, 0.006, 0.003. But the V5 of normal lung in the IMRT plan had no statistical differences compared with the CRT+ARC plan;see Table 8 for details.As for B-P, the V15, V20, V25, V30, V35, and V50 of B-P in the IMRT plan were higher than the CRT+ARC plan, and the differences were statistically significant,t=0.616, -0.794, -3.705, -4.924,-3.716, p=0.042, 0.025, 0.001, 0.001, 0.005. The other dosimetric parameters of B-P in the IMRT plan had no statistical differences compared with the CRT+ARC plan;see Table 8 for details.


## 4.8. ARC Plan versus CRT+IMRT Plan

As shown in Table9, the minimum dose, the median dose, the conformity index, and the homogeneity index of PTV in the ARC plan were better than the CRT+IMRT plan, and the differences were statistically significant,t=3.861, 2.480, 8.381, -2.795, p=0.004, 0.035, 0.001, 0.021.The other dosimetric parameters of PTV in the ARC plan had no statistical differences compared with the CRT+IMRT plan.Table 9
Comparisons of PTV, OAR, and B-P dosimetric parameters between ARC plan and CRT+IMRT plancGy,x-±s.
Dosimetric parameters ARC plan CRT+IMRT plan Difference tvalue Pvalue PTV Minimum dose/cGy 4285.12±159.09 4051.12±183.68 234.00±191.68 3.861 0.004 Maximum dose/cGy 5348.30±61.22 5373.66±103.43 -25.36±122.01 -0.657 0.527 Median dose/cGy) 5025.60±6.27 5017.78±9.25 7.82±9.97 2.480 0.035 Conformity index 0.88±0.02 0.80±0.03 0.08±0.03 8.381 0.001 Homogeneity index 0.21±0.04 0.27±0.05 -0.05±0.06 -2.795 0.021 V105 (%) 0.74±.84 3.48±5.16 -2.74±5.08 -1.707 0.122 OAR Spinal cord Maximum dose 2383.08±353.89 3181.48±556.33 -798.40±303.74 -8.312 0.001 Esophagus V50 (%) 17.79±14.08 14.68±13.39 4.80±7.56 2.007 0.076 Maximum dose 5270.17±109.33 5205.15±96.40 -341.53±120.23 -0.898 0.392 Heart V20 (%) 20.78±21.65 20.76±21.46 -6.78±8.27 -2.591 0.029 V30 (%) 9.83±10.15 13.12±15.14 -6.46±9.26 -2.205 0.055 V40 (%) 4.87±5.24 5.32±5.49 -1.54±2.34 -2.090 0.066 V45 (%) 3.59±3.84 3.86±4.20 -0.96±1.81 -1.676 0.128 Mean dose 932.07±702.92 983.30±742.64 -284.71±339.66 -2.651 0.026 Normal lung V5 (%) 49.59±6.17 46.88±7.19 9.18±2.45 11.829 0.001 V10 (%) 35.13±7.42 31.74±6.64 4.85±4.05 3.791 0.004 V13 (%) 30.31±6.38 24.71±4.66 4.49±2.86 4.954 0.001 V20 (%) 22.22±4.48 17.95±2.56 1.54±1.52 3.185 0.011 V30 (%) 8.63±1.47 11.34±2.11 -2.49±2.09 -3.761 0.004 Mean dose 1040.41±147.82 1001.52±127.12 -29.12±286.09 -0.322 0.755 B-P V5(%) 26.15±3.14 20.49±2.71 5.66±1.76 10.143 0.001 V10(%) 16.54±2.41 14.32±2.43 2.23±1.03 6.824 0.001 V15(%) 10.97±1.80 11.92±3.92 -0.94±3.24 -0.920 0.382 V20(%) 6.46±1.43 10.04±3.22 -3.58±2.41 -4.684 0.001 V25(%) 3.72±0.93 8.32±2.76 -4.60±2.19 -6.648 0.001 V30(%) 2.13±0.55 5.76±2.33 -3.63±-1.99 -5.754 0.001 V35(%) 1.22±0.29 3.27±1.80 -2.05±1.65 -3.921 0.004 V40(%) 0.66±0.14 1.72±1.46 -1.05±1.39 -2.397 0.040 V45(%) 0.25±0.04 0.87±1.03 -0.62±1.02 -2.136 0.049 V50(%) 0.00±0.0 0.06±0.06 -0.05±0.05 10.143 0.007As for OARs, the maximum dose of spinal cord, the maximum dose and the V50 (%) of esophagus in the ARC plan had no statistical differences compared with the CRT+IMRT plan. The V20 (%) and the median dose of heart in the ARC plan were lower than the CRT+IMRT plan, and the differences were statistically significant,t=-2.591, -2.651, p=0.029, 0.026. The other dosimetric parameters of heart in the ARC plan had no statistical differences compared with the CRT+IMRT plan. The V5 (%), V10 (%), V13 (%), and V20 (%) of normal lung in the ARC plan were higher than the CRT+IMRT plan, and the differences were statistically significant,t=11.829, 3.791, 4.954, 3.185, -3.761, p=0.001, 0.004, 0.001, 0.011, 0.004. But the V30 (%) in the ARC plan was lower than the CRT+IMRT plan, and the difference was statistically significant,t=-3.761, p=0.004. The mean dose of normal lung in the ARC plan had no statistical differences compared with the CRT+IMRT plan;see Table 9 for details.As for B-P, the V5 and V10 of B-P in the ARC plan were higher than the CRT+IMRT plan, and the differences were statistically significant,t=10.143, 6.824, p=0.001, 0.001. However, the V20, V25, V30, V35,V40, V45, and V50 of B-P in the ARC plan were lower than the CRT+IMRT plan, and the differences were statistically significant,t=-4.684, -6.648, -5.754, -3.921, -2.397, -2.136, 10.143, p=0.001, 0.001, 0.001, 0.004, 0.040, 0.049, 0.007. The V15 of B-P in the ARC plan had no statistical differences compared with the CRT+IMRT plan;see Table 9 for details.


## 4.9. ARC Plan versus CRT+ARC Plan

As shown in Table10, the conformity index of PTV in the ARC pan was better than the CRT+ARC plan, and the difference was statistically significant,t=3.500, p=0.007.The other dosimetric parameters of PTV in the ARC plan had no statistical differences compared with the CRT+ARC plan.Table 10
Comparisons of PTV, OAR, and B-P dosimetric parameters between ARC plan and CRT+ARC plancGy,x-±s.
Dosimetric parameters ARC plan CRT+ARC plan Difference tvalue Pvalue PTV Minimum dose/cGy 4285.12±159.09 4305.23±114.48 -20.11±157.12 -0.405 0.695 Maximum dose/cGy 5348.30±61.22 5328.32±58.00 19.98±37.33 1.692 0.125 Median dose/cGy) 5025.60±6.27 5068.44±77.68 -42.84±79.30 -1.708 0.122 Conformity index 0.88±0.02 0.86±0.02 0.01±0.01 3.500 0.007 Homogeneity index 0.21±0.04 0.20±0.03 0.01±0.03 0.633 0.543 V105 (%) 0.74±.84 3.75±9.42 -3.01±9.58 -0.993 0.347 OAR Spinal cord Maximum dose 2383.08±353.89 2870.81±535.92 -487.73±224.92 -6.857 0.001 Esophagus V50 (%) 17.79±14.08 17.02±12.75 2.45±5.72 1.358 0.207 Maximum dose 5270.17±109.33 5229.34±79.93 -365.72±383.31 -0.954 0.365 Heart V20 (%) 20.78±21.65 20.56±21.20 -6.57±8.02 -2.592 0.029 V30 (%) 9.83±10.15 14.39±13.89 -7.72±7.93 -3.080 0.013 V40 (%) 4.87±5.24 4.88±4.73 -1.09±1.58 -2.193 0.056 V45 (%) 3.59±3.84 2.94±2.42 -0.04±0.19 -0.734 0.481 Mean dose 932.07±702.92 872.64±788.90 -174.05±470.84 -1.169 0.272 Normal lung V5 (%) 49.59±6.17 48.77±9.22 7.30±5.31 4.346 0.002 V10 (%) 35.13±7.42 28.30±5.43 8.30±2.97 8.832 0.001 V13 (%) 30.31±6.38 22.40±4.28 6.79±3.67 5.856 0.001 V20 (%) 22.22±4.48 14.74±2.08 4.75±2.39 6.281 0.001 V30 (%) 8.63±1.47 10.36±0.81 -1.50±1.06 -4.461 0.002 Mean dose 1040.41±147.82 952.15±120.92 20.24±91.13 0.222 0.829 B-P V5(%) 26.15±3.14 25.22±12.40 0.93±11.79 0.250 0.808 V10(%) 16.54±2.41 14.86±6.45 1.68±6.01 0.885 0.399 V15(%) 10.97±1.80 10.13±4.22 0.85±3.89 0.692 0.506 V20(%) 6.46±1.43 7.99±2.65 -1.53±2.15 -2.250 0.051 V25(%) 3.72±0.93 6.83±1.99 -3.11±1.51 -6.512 0.001 V30(%) 2.13±0.55 5.33±1.80 -3.19±1.51 -6.645 0.001 V35(%) 1.22±0.29 3.42±1.89 -2.19±1.74 -3.973 0.003 V40(%) 0.66±0.14 1.58±1.71 -0.92±1.65 -1.766 0.111 V45(%) 0.25±0.04 0.68±1.19 -0.43±1.18 -1.147 0.281 V50(%) 0.00±0.0 0.12±0.33 -0.11±0.32 -1.105 0.298As for OARs, the maximum dose of spinal cord in the ARC plan was lower than the CRT+ARC plan, and the difference was statistically significant,t=-6.857, p=0.001. The maximum dose and the V50 (%) of esophagus in the ARC plan had no statistical differences compared with the CRT+ARC plan. The V20 (%) and the V30 (%) of heart in the ARC plan were lower than the CRT+ARC plan, and the differences were statistically significant,t=-2.592, -3.080, p=0.029, 0.013. The other dosimetric parameters of heart in the ARC plan had no statistical differences compared with the CRT+ARC plan. The V5 (%), V10 (%), V13 (%), and V20 (%) of normal lung in the ARC plan were higher than the CRT+ARC plan, and the differences were statistically significant,t=4.346, 8.832, 5.856, 6.281, p=0.002, 0.001, 0.001, 0.001. But the V30 (%) in the ARC plan was lower than the CRT+ARC plan, and the difference was statistically significant,t=-4.461, p=0.002. The mean dose of normal lung in CRT plan had no statistical difference compared with the IMRT plan;see Table 10 for details.As for B-P, the V25, V30, and V35 of B-P in the ARC plan were lower than the CRT+ARC plan, and the differences were statistically significant,t=-6.512,-6.645, -3.973, p=0.001, 0.001, 0.003. The other dosimetric parameters of B-P in the ARC plan had no statistical differences compared with the CRT+ARC plan;see Table 10 for details.


## 4.10. CRT+IMRT Plan versus CRT+ARC Plan

As shown in Table11, the minimum dose, the conformity index, and the homogeneity index of PTV in the CRT+IMRT plan were worse than the CRT+ARC plan, and the differences were statistically significant,t=-6.053, -7.334, 5.364, p=0.001, 0.001, 0.001.The other dosimetric parameters of PTV in the CRT+IMRT plan had no statistical differences compared with the CRT+ARC plan.Table 11
Comparisons of PTV, OAR, and B-P dosimetric parameters between CRT+IMRT plan and CRT+ARC plancGy,x-±s.
Dosimetric parameters CRT+IMRT plan CRT+ARC plan Difference tvalue Pvalue PTV Minimum dose/cGy 4051.12±183.68 4305.23±114.48 -254.11±132.76 -6.053 0.001 Maximum dose/cGy 5373.66±103.43 5328.32±58.00 45.34±115.42 1.242 0.246 Median dose/cGy) 5017.78±9.25 5068.44±77.68 -50.66±74.52 -2.150 0.060 Conformity index 0.80±0.03 0.86±0.02 0.07±0.03 -7.334 0.001 Homogeneity index 0.27±0.05 0.20±0.03 0.06±0.03 5.364 0.001 V105 (%) 3.48±5.16 3.75±9.42 -0.27±11.52 -0.074 0.943 OAR Spinal cord Maximum dose 3181.48±556.33 2870.81±535.92 310.67±262.39 3.744 0.005 Esophagus V50 (%) 14.68±13.39 17.02±12.75 -2.34±4.33 -1.709 0.122 Maximum dose 5205.15±96.40 5229.34±79.93 -24.19±73.44 -1.042 0.325 Heart V20 (%) 20.76±21.46 20.56±21.20 0.20±0.53 1.178 0.269 V30 (%) 13.12±15.14 14.39±13.89 -1.27±2.18 -1.843 0.098 V40 (%) 5.32±5.49 4.88±4.73 0.45±0.88 1.617 0.140 V45 (%) 3.86±4.20 2.94±2.42 0.92±1.88 1.547 0.156 Mean dose 983.30±742.64 872.64±788.90 110.66±322.92 1.084 0.307 Normal lung V5 (%) 46.88±7.19 48.77±9.22 -1.88±5.28 -1.127 0.289 V10 (%) 31.74±6.64 28.30±5.43 3.44±3.07 3.546 0.006 V13 (%) 24.71±4.66 22.40±4.28 2.31±2.17 3.376 0.008 V20 (%) 17.95±2.56 14.74±2.08 3.22±1.45 7.026 0.001 V30 (%) 11.34±2.11 10.36±0.81 0.99±2.04 1.528 0.161 Mean dose 1001.52±127.12 952.15±120.92 49.37±30.51 5.117 0.001 B-P V5(%) 20.49±2.71 25.22±12.40 -4.73±11.15 -1.341 0.213 V10(%) 14.32±2.43 14.86±6.45 -0.54±5.74 -0.300 0.771 V15(%) 11.92±3.92 10.13±4.22 1.79±4.96 1.143 0.283 V20(%) 10.04±3.22 7.99±2.65 2.05±3.37 1.923 0.087 V25(%) 8.32±2.76 6.83±1.99 1.49±2.74 1.715 0.120 V30(%) 5.76±2.33 5.33±1.80 0.43±2.47 0.553 0.594 V35(%) 3.27±1.80 3.42±1.89 -0.15±2.56 -0.186 0.856 V40(%) 1.72±1.46 1.58±1.71 0.13±2.19 0.195 0.850 V45(%) 0.87±1.03 0.68±1.19 0.19±1.57 0.393 0.703 V50(%) 0.06±0.06 0.12±0.33 -0.06±0.32 -0.553 0.594As for OARs, the maximum dose of spinal cord in the CRT+IMRT plan was higher than the CRT+ARC plan, and the difference was statistically significant,t=3.744, p=0.005. The dosimetric parameters of the esophagus and the heart in the CRT+IMRT plan had no statistical differences compared with the CRT+ARC plan. The V10 (%), V13 (%), V20 (%), and the mean dose of normal lung the CRT+IMRT plan were higher than the CRT+ARC plan, and the differences were statistically significant,t=3.546, 3.376, 7.026, p=0.006, 0.008, 0.001. The V30 (%) and the mean dose of normal lung the CRT+IMRT plan had no statistical differences compared with the CRT+ARC plan;see Table 11 for details.As for B-P, all the dosimetric parameters of B-P in the CRT+IMRT plan had no statistical differences compared with the CRT+ARC plan;see Table 11 for details.


## 5. Discussion

As shown in the above results, the conformity index of PTV in the CRT plan was worse than all the other plans, the IMRT, ARC, CRT+IMRT, and CRT+ARC plan. By the CRT plan compared with the IMRT and CRT+IMRT plan, the minimum dose of PTV was better. Nevertheless, as for PTV, the CRT plan compared with the ARC and CRT+ARC plan had no any dosimetry advantages. As for OARs, the CRT plan had dosimetry advantages in esophagus than all the other plans. The CRT plan had dosimetry advantages in the V30 (%) of heart than the CRT+ARC plan. But as for the other OARs, the CRT plan had no any dosimetry advantages compared with all the other plans. As for B-P, the dosimetry parameters in the CRT plan were worse than the IMRT and ARC plan, but had no statistical differences compared with the CRT+IMRT and the CRT+ARC plan.The studies [5–8] about PORT in stage IIIA-N2 NSCLC patients in recent years mostly adopted the CRT technique. Though the CRT is relatively safe and stable with higher marginal dose of tumor, the dosimetry advantages of the CRT are not obvious as discussed above, perhaps due to the limitations of the technique itself. In addition, if the volume of PTV is a little larger, it maybe not meet the requirement of prescription dose and make the organ not exceeding the limit dose at the same time.As the IMRT plan compared with all the other plans, the minimum dose of PTV in the IMRT plan was worse than the CRT plan, but the conformity index was better. The dosimetry parameters of PTV in the IMRT plan had no statistical differences compared with the CRT+IMRT plan. The minimum dose, the conformity index, and the homogeneity index of PTV in the IMRT plan were worse than the ARC plan and the CRT+ARC plan. As for OARs, except the maximum dose of esophagus, the dose of all the other OARs in the IMRT plan was lower than the CRT plan. The dose of spinal cord and heart in the IMRT plan was lower than the CRT+IMRT plan, but the dose of esophagus and normal lung in the IMRT plan was higher than the CRT+IMRT plan. The dosimetry parameters of spinal cord and esophagus in the IMRT plan had no statistical differences compared with the ARC and the CRT+ARC plan. The V20 (%) and V30 (%) of heart in the IMRT plan were higher than the ARC plan. The V20 (%) of normal lung in the IMRT plan was higher than the ARC plan, but the V5 (%) and V10 (%) were lower than the ARC plan. The V30 (%) of heart in the IMRT plan was higher than the CRT+ARC plan, but the V10 (%), V15 (%), V20 (%), V30 (%), and mean dose of normal lung in the IMRT plan were all higher than the CRT+ARC plan. As for B-P, the dosimetry parameters in the IMRT plan were all lower than the CRT plan. The V20~50 of B-P in the IMRT plan were all lower than the CRT+ IMRT plan, but the V5~10 were higher than the CRT+ IMRT plan. The V15~35 of B-P in the IMRT plan were all higher than the ARC plan, but the V5~10 were lower than the ARC plan. The V20~35 of B-P in the IMRT plan were all lower than the ARC plan, but the V15 was higher than the ARC plan.The studies about PORT in stage IIIA-N2 NSCLC patients in recent years which adopted the IMRT technique were not many. Abigail T Berman et al. [9] reported an in silico comparative analysis of passive scattering proton therapy (PSPT) and intensity modulated proton therapy (IMPT) with intensity modulated photon beam radiotherapy (IMRT) PORT and concluded that IMPT demonstrates a large decrease in dose to all OARs, while PSPT reduces the low dose lung bath and increases the volume of lung receiving high dose, and reductions are seen in dosimetric parameters predictive of radiation pneumonitis and cardiac morbidity and mortality, and this reduction may correlate with a decrease in dose-limiting toxicity and improve the therapeutic ratio. Jill S. Remick et al. [10] investigated the survival outcomes and early toxicity profile of PORT with proton beam therapy (PBT) versus IMRT for non-small-cell lung cancer in a cohort of 61 patients with positive microscopic margins and/or positive N2 lymph nodes and found that postoperative PBT in locally advanced NSCLC is well-tolerated and has similar excellent short-term outcomes when compared with IMRT. In the above two studies, IMRT had no dosimetry advantages compared with IMPT, PSPT, and PBT. In our study as discussed above, the IMRT had certain dosimetry advantages compared with CRT, CRT+IMRT, and CRT+ARC.Comparing the ARC plan with all other plans, the ARC plan had dosimetry advantages in PTV than all the other plans. As for OARs, the ARC plan had dosimetry advantages in spinal cord, heart and normal lung compared with the CRT plan, but had no dosimetry advantages in esophagus. Nevertheless, when compared with the CRT+ARC plan, the ARC plan had dosimetry advantages in spinal cord, heart and V30 (%) of normal lung, and had no dosimetry advantages in V5 (%), V10 (%), V13 (%), and V20 (%) of normal lung. The ARC plan had dosimetry advantages in heart and V20 (%) of normal lung compared with the IMRT plan, but had no dosimetry advantages in V5 (%) and V10 (%) of normal lung. As well as compared with the CRT+IMRT plan, the ARC plan had dosimetry advantages in spinal cord, heart, and V30 (%) of normal lung and had no dosimetry advantages in V5 (%),V10 (%), V13 (%), and V20 (%) of normal lung. As for B-P, the ARC plan had dosimetry advantages compared to the CRT plan and the CRT+ARC plan. The ARC plan had no dosimetry advantages in V5 (%) and V10 (%) of B-P compared with the IMRT plan and the CRT+IMRT plan, but had dosimetry advantages in V15~35 (%) of B-P compared to the IMRT plan, and had dosimetry advantages in V20~50 (%) of B-P compared to the CRT+IMRT plan.The studies about PORT in stage IIIA-N2 NSCLC patients in recent years that adopted the ARC technique were fewer. Huan-Huan Wang et al. [11] had evaluated the ideal timing of PORT in the management of completely resected (R0) Stage IIIA-N2 NSCLC. In their study, PORT was administered using not only CRT and IMRT, but also VMAT (ARC). Nevertheless, the study did not give detailed technique parameters and patients were not grouped according to different techniques. In our study as discussed above, the ARC plan had absolute dosimetry advantages in PTV, but had no dosimetry advantages in low dose area of normal lung and B-P.Comparing the CRT+IMRT plan with all other plans, the CRT+IMRT plan had no dosimetry differences in PTV compared to the IMRT plan and had no dosimetry advantages in PTV compared with the ARC and CRT+ARC plan. The median dose and conformity of PTV in the CRT+IMRT were better than the CRT plan, but the minimum dose and homogeneity index PTV in the CRT+IMRT were worse than the CRT plan. As for OARs, the CRT+IMRT plan had no dosimetry advantages in esophagus compared to the CRT plan, but had dosimetry advantages in heart and normal lung compared with the CRT plan. The CRT+IMRT plan compared with the IMRT plan and ARC plan had no dosimetry advantages in spinal cord, heart, and the V30 (%) of normal lung, but had dosimetry advantages in the V5 (%), V10 (%), V13 (%), and V20 (%) of normal lung. The CRT+IMRT plan had no dosimetry advantages in all the OARs compared with the CRT +ARC plan. As for B-P, the CRT+IMRT plan had dosimetry advantages except the V30 (%) of B-P compared to the CRT plan. As for the CRT+IMRT plan compared with the IMRT and ARC plan, the CRT+IMRT plan had dosimetry advantages in low dose area of B-P and had no dosimetry advantages in high dose area of B-P. The CRT+IMRT plan had no dosimetry differences compared to the CRT +ARC plan.There was no study about PORT in stage IIIA-N2 NSCLC patients in recent years which adopted the CRT+IMRT technique. Gerrit J. Blom et al. [12] compared the dosimetry characteristics of Hybrid-IMRT(CRT+IMRT) with RapidArc (ARC) in locally advanced non-small-cell lung cancer. It was challenging for 60-66Gy to deliver to large target volumes due to the need to spare OARs, so Hybrid-IMRT is currently their standard technique in locally advanced non-small-cell lung cancer. Though the target volumes in PORT patients were not very large and the prescriptions were not very high generally, the dose limits of OARs were lower than patients who had no surgery. Therefore, investigating the dosimetry characteristics of the CRT+IMRT technique in PORT patients is also necessary.The CRT+ARC plan had dosimetry advantages in PTV compared to the CRT plan, IMRT plan, and CRT+IMRT plan, but the conformal index of PTV in the CRT+ARC plan was worse than the ARC plan. As for OARs, the CRT+ARC plan had no dosimetry advantages in spinal cord and the V30 (%) of heart compared with the CRT plan, but had dosimetry advantages in V20 (%), V40 (%), V45 (%), and mean dose of heart and normal lung. The CRT+ARC plan had dosimetry advantages in normal lung compared with the IMRT plan. CRT+ARC plan had no dosimetry advantages in spinal cord and the V30 (%) of normal lung compared with the ARC plan, but had dosimetry advantages in heart and V5 (%), V10 (%), V13 (%), and V20 (%) of normal lung. The CRT+ARC plan had dosimetry advantages in spinal cord and normal lung compared to the CRT+IMRT plan. As for B-P, the CRT+ARC plan had dosimetry advantages in V25~35 of B-P compared to the CRT plan, and had dosimetry advantages in V10~15 of B-P compared to the IMRT plan. The CRT+ARC plan had no dosimetry advantages in B-P compared with the ARC plan, and had no dosimetry differences in B-P compared with the IMRT plan.There was also no study about PORT in stage IIIA-N2 NSCLC patients in recent years which adopted the CRT+ARC technique. John Agapito [13] compared the dosimetry characteristics of CRT with hybrid-VMAT (CRT+ARC) in locally advanced non-small-cell lung cancer, and concluded that the hybrid technique shows promise, but the quantity assurance implications of motion at treatment needs careful consideration. As discussed above, the CRT+ARC plan compared with the ARC plan, though conformal index of PTV was worse, the low dose area of normal lung was better. The studies by Len AM. et al. [14] and Schallen kamp JM. et al. [15] indicated that the radiation pneumonitis was related to the low dose areas of normal lung. If the low dose areas of ARC plan for a patient exceed the limits dose, a CRT+ARC plan may be a better choice.


## 6. Conclusion

According to the above analysis, no plan had absolute dosimetry advantages than any other plans. In the clinic, the plans could be chosen according to their dosimetry characteristics. For example, for a patient who needs protection especially for esophagus, the CRT plan could be chosen. If a plan for a patient needs a good dosimetry distribution for PTV, the ARC plan could be chosen. Another example is that the volume of PTV is a little large and the lung of a patient needs better protection, then the CRT+ARC plan could be chosen. Of course, in the course of implementation of the above radiotherapy techniques, if modern auxiliary equipment can be incorporated with them, they can be better implemented in patients. The modern auxiliary equipment includes respiratory gate control [16, 17], CBCT image guidance technology [18–20], and so on. In future clinical studies, we hope to see more applications of these advanced radiotherapy techniques and radiotherapy auxiliary equipment. Moreover, detailed technical parameters can be given, and each radiotherapy technique can be grouped differently to study.



---

*Source: 8989241-2019-03-18.xml*